Medicinal plants used in the treatment of human immunodeficiency virus

International Journal of Molecular Sciences

Volumn 19, Issue 5, 2018, Pages

  Salehi, Bahare ^a,b   Anil Kumar, Nanjangud V ^c   Şener, Bilge ^d   Sharifi Rad, Mehdi ^e   Kılıç, Mehtap ^d   Mahady, Gail B ^f   Vlaisavljevic, Sanja ^g   Iriti, Marcello ^h   Kobarfard, Farzad ^b   Setzer, William N ⁱ   Ayatollahi, Seyed Abdulmajid ^b,j   Ata, Athar ^j   Sharifi Rad, Javad ^b,j  

^a Shahid Beheshti University of Medical Sciences   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MANIPAL INSTITUTE OF TECHNOLOGY   (India)

^d GAZI UNIVERSITY   (Turkey)

^e ZABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^g UNIVERSITY OF NOVI SAD   (Serbia)

^h UNIVERSITY OF MILAN   (Italy)

ⁱ The University of Winnipeg ^*  (United States)

^j UNIVERSITY OF WINNIPEG   (Canada)

more..

Author keywords

Acquired immune deficiency syndrome; Antiviral; Drug discovery; Pharmacognosy; Phytochemistry

Indexed keywords

NATURAL PRODUCT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BIOLOGICAL PRODUCT; PLANT EXTRACT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIRETROVIRAL THERAPY; ARTEMISIA; ASTRAGALUS (PLANT); CALENDULA; CALOPHYLLUM; CASSIA; CD4+ T LYMPHOCYTE; CHELIDONIUM; COMBRETUM; DIOSPYROS; GALANTHUS; GARCINIA; HELICHRYSUM; HOODIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERICUM; HYSSOPUS PLANT; JUSTICIA GENDARUSSA; MEDICINAL PLANT; MENINGITIS; MOMORDICA; PHYLLANTHUS; REVIEW; VIRUS LOAD; CHEMISTRY; CLINICAL TRIAL (TOPIC); DRUG DEVELOPMENT; DRUG EFFECT; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; PHYSIOLOGY; SECONDARY METABOLISM; TREATMENT OUTCOME; VIROLOGY;

ANTI-HIV AGENTS; BIOLOGICAL PRODUCTS; CLINICAL TRIALS AS TOPIC; DRUG DISCOVERY; HIV INFECTIONS; HIV-1; HUMANS; PLANT EXTRACTS; PLANTS, MEDICINAL; SECONDARY METABOLISM; TREATMENT OUTCOME;

EID: 85047056765     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms19051459     Document Type: Review

References (394)

1. Deeks, S.G.; Overbaugh, J.; Phillips, A.; Buchbinder, S. HIV infection. Nat. Rev. Dis. Prim. 2015, 1, 15035. [CrossRef] [PubMed]
2. World Health Organization (WHO). 2017. Available online: http://www.who.int/hiv/data/epi_plhiv_ 2016_regions.png?ua=1 (accessed on 1 December 2017).
3. Kharsany, A.B.; Karim, Q.A. HIV infection and AIDS in sub-saharan Africa: Current status, challenges and opportunities. Open AIDS J. 2016, 10, 34–48. [CrossRef] [PubMed]
4. Worobey, M.; Watts, T.D.; McKay, R.A.; Suchard, M.A.; Granade, T.; Teuwen, D.E.; Koblin, B.A.; Heneine, W.; Lemey, P.; Jaffe, H.W. 1970s and ‘patient 0’ HIV-1 genomes illuminate early HIV/AIDS history in north america. Nature 2016, 539, 98–101. [CrossRef] [PubMed]
5. Auerbach, D.M.; Darrow, W.W.; Jaffe, H.W.; Curran, J.W. Cluster of cases of the acquired immune deficiency syndrome: Patients linked by sexual contact. Am. J. Med. 1984, 76, 487–492. [CrossRef]
6. Centers for Disease Control. A cluster of Kaposi’s sarcoma and Pneumocystis carinii pneumonia among homosexual male residents of Los Angeles and Orange Counties, California. MMWR Morb. Mortal. Wkly. Rep. 1982, 31, 305–307.
7. Moir, S.; Chun, T.-W.; Fauci, A.S. Pathogenic mechanisms of HIV disease. Annu. Rev. Pathol. Mech. Dis. 2011, 6, 223–248. [CrossRef] [PubMed]
8. Harden, V.A.; Fauci, A. AIDS at 30: A History; Potomac Books, Inc.: Lincoln, NE, USA, 2012.
9. Piot, P.; Karim, S.S.A.; Hecht, R.; Legido-Quigley, H.; Buse, K.; Stover, J.; Resch, S.; Ryckman, T.; Møgedal, S.; Dybul, M. Defeating AIDS—Advancing global health. Lancet 2015, 386, 171–218. [CrossRef]
10. Günthard, H.F.; Aberg, J.A.; Eron, J.J.; Hoy, J.F.; Telenti, A.; Benson, C.A.; Burger, D.M.; Cahn, P.; Gallant, J.E.; Glesby, M.J. Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society—USA panel. JAMA 2014, 312, 410–425. [CrossRef] [PubMed]
11. Auvert, B.; Taljaard, D.; Lagarde, E.; Sobngwi-Tambekou, J.; Sitta, R.; Puren, A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: The ANRS 1265 trial. PLoS Med. 2005, 2, e298. [CrossRef] [PubMed]
12. Bailey, R.C.; Moses, S.; Parker, C.B.; Agot, K.; Maclean, I.; Krieger, J.N.; Williams, C.F.; Campbell, R.T.; Ndinya-Achola, J.O. Male circumcision for HIV prevention in young men in Kisumu, Kenya: A randomised controlled trial. Lancet 2007, 369, 643–656. [CrossRef]
13. Anderson, S.-J.; Cherutich, P.; Kilonzo, N.; Cremin, I.; Fecht, D.; Kimanga, D.; Harper, M.; Masha, R.L.; Ngongo, P.B.; Maina, W. Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: A modelling study. Lancet 2014, 384, 249–256. [CrossRef]
14. Cohen, M.S.; Chen, Y.Q.; McCauley, M.; Gamble, T.; Hosseinipour, M.C.; Kumarasamy, N.; Hakim, J.G.; Kumwenda, J.; Grinsztejn, B.; Pilotto, J.H. Prevention of HIV-1 infection with early antiretroviral therapy. N. Engl. J. Med. 2011, 365, 493–505. [CrossRef] [PubMed]
15. Guay, L.A.; Musoke, P.; Fleming, T.; Bagenda, D.; Allen, M.; Nakabiito, C.; Sherman, J.; Bakaki, P.; Ducar, C.; Deseyve, M. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999, 354, 795–802. [CrossRef]
16. Maartens, G.; Celum, C.; Lewin, S.R. HIV infection: Epidemiology, pathogenesis, treatment, and prevention. Lancet 2014, 384, 258–271. [CrossRef]
17. Günthard, H.F.; Saag, M.S.; Benson, C.A.; Del Rio, C.; Eron, J.J.; Gallant, J.E.; Hoy, J.F.; Mugavero, M.J.; Sax, P.E.; Thompson, M.A. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2016 recommendations of the International Antiviral Society—USA panel. JAMA 2016, 316, 191–210. [CrossRef] [PubMed]
18. Gravatt, L.A.H.; Leibrand, C.R.; Patel, S.; McRae, M. New drugs in the pipeline for the treatment of HIV: A review. Curr. Infect. Dis. Rep. 2017, 19, 42. [CrossRef] [PubMed]
19. Sharifi-Rad, J. Herbal antibiotics: Moving back into the mainstream as an alternative for “superbugs”. Cell. Mol. Biol. 2016, 62, 1–2. [PubMed]
20. + T cells to HIV by increasing the kinetics and efficiency of postentry viral events. J. Virol. 2014, 88, 10803–10812. [CrossRef] [PubMed]
21. WHO. In vitro screening of traditional medicines for anti-HIV activity: Memorandum from a WHO meeting. Bull. World Health Organ. 1989, 87, 613–618.
22. WHO. Report of a Who Informal Consultation on Traditional Medicine and AIDS: In Vitro Screening for Anti-HIV Activity; WHO: Geneva, Switzerland, 1989.
23. Kurapati, K.R.V.; Atluri, V.S.; Samikkannu, T.; Garcia, G.; Nair, M.P. Natural products as anti-HIV agents and role in HIV-associated neurocognitive disorders (hand): A brief overview. Front. Microbiol. 2016, 6, 1444. [CrossRef] [PubMed]
24. Deng, X.; Jiang, M.; Zhao, X.; Liang, J. Efficacy and safety of traditional Chinese medicine for the treatment of acquired immunodeficiency syndrome: A systematic review. J. Tradit. Chin. Med. 2014, 34, 1–9. [CrossRef]
25. Sharifi-Rad, M.; Varoni, E.M.; Salehi, B.; Sharifi-Rad, J.; Matthews, K.R.; Ayatollahi, S.A.; Kobarfard, F.; Ibrahim, S.A.; Mnayer, D.; Zakaria, Z.A. Plants of the genus Zingiber as a source of bioactive phytochemicals: From tradition to pharmacy. Molecules 2017, 22, 2145. [CrossRef] [PubMed]
26. Sharifi-Rad, J.; Salehi, B.; Varoni, E.M.; Sharopov, F.; Yousaf, Z.; Ayatollahi, S.A.; Kobarfard, F.; Sharifi-Rad, M.; Afdjei, M.H.; Sharifi-Rad, M. Plants of the Melaleuca genus as antimicrobial agents: From farm to pharmacy. Phytother. Res. 2017, 31, 1475–1494. [CrossRef] [PubMed]
27. Salehi, B.; Ayatollahi, S.; Segura-Carretero, A.; Kobarfard, F.; Contreras, M.; Faizi, M.; Sharifi-Rad, M.; Tabatabai, S.; Sharifi-Rad, J. Bioactive chemical compounds in Eremurus persicus (Joub. & Spach) Boiss. Essential oil and their health implications. Cell. Mol. Biol. 2017, 63, 1–7. [PubMed]
28. Sharifi-Rad, J.; Salehi, B.; Schnitzler, P.; Ayatollahi, S.; Kobarfard, F.; Fathi, M.; Eisazadeh, M.; Sharifi-Rad, M. Susceptibility of herpes simplex virus type 1 to monoterpenes thymol, carvacrol, p-cymene and essential oils of Sinapis arvensis L., Lallemantia royleana Benth. and Pulicaria vulgaris Gaertn. Cell. Mol. Biol. 2017, 63, 42–47. [CrossRef] [PubMed]
29. Sharifi-Rad, J.; Ayatollahi, S.A.; Varoni, E.M.; Salehi, B.; Kobarfard, F.; Sharifi-Rad, M.; Iriti, M.; Sharifi-Rad, M. Chemical composition and functional properties of essential oils from Nepeta schiraziana Boiss. Farmacia 2017, 65, 802–812.
30. Sharifi-Rad, J.; Salehi, B.; Stojanović-Radić, Z.Z.; Fokou, P.V.T.; Sharifi-Rad, M.; Mahady, G.B.; Sharifi-Rad, M.; Masjedi, M.-R.; Lawal, T.O.; Ayatollahi, S.A. Medicinal plants used in the treatment of tuberculosis-ethnobotanical and ethnopharmacological approaches. Biotechnol. Adv. 2017. [CrossRef] [PubMed]
31. Salehi, B.; Zucca, P.; Sharifi-Rad, M.; Pezzani, R.; Rajabi, S.; Setzer, W.; Varoni, E.; Iriti, M.; Kobarfard, F.; Sharifi-Rad, J. Phytotherapeutics in cancer invasion and metastasis. Phytother. Res. 2018, 1–25. [CrossRef] [PubMed]
32. Sahraie-Rad, M.; Izadyari, A.; Rakizadeh, S.; Sharifi-Rad, J. Preparation of strong antidandruff shampoo using medicinal plant extracts: A clinical trial and chronic dandruff treatment. Jundishapur J. Nat. Pharm. Prod. 2015, 10, e21517. [CrossRef]
33. Bagheri, G.; Mirzaei, M.; Mehrabi, R.; Sharifi-Rad, J. Cytotoxic and antioxidant activities of Alstonia scholaris, Alstonia venenata and Moringa oleifera plants from India. Jundishapur J. Nat. Pharm. Prod. 2016, 11, e31129. [CrossRef]
34. Stojanović-Radić, Z.; Pejčić, M.; Stojanović, N.; Sharifi-Rad, J.; Stanković, N. Potential of Ocimum basilicum L. and Salvia officinalis L. essential oils against biofilms of P. aeruginosa clinical isolates. Cell. Mol. Biol. 2016, 62, 27–32. [PubMed]
35. Sharifi-Rad, J.; Hoseini-Alfatemi, S.; Sharifi-Rad, M.; Miri, A. Phytochemical screening and antibacterial activity of different parts of the Prosopis farcta extracts against methicillin-resistant Staphylococcus aureus (MRSA). Min. Biotecnol. 2014, 26, 287–293.
36. Sharifi-Rad, J.; Sureda, A.; Tenore, G.C.; Daglia, M.; Sharifi-Rad, M.; Valussi, M.; Tundis, R.; Sharifi-Rad, M.; Loizzo, M.R.; Ademiluyi, A.O. Biological activities of essential oils: From plant chemoecology to traditional healing systems. Molecules 2017, 22, 70. [CrossRef] [PubMed]
37. Sharifi-Rad, J.; Fallah, F.; Setzer, W.; Entezari, R.H.; Sharifi-Rad, M. Tordylium persicum Boiss. & Hausskn extract: A possible alternative for treatment of pediatric infectious diseases. Cell. Mol. Biol. 2016, 62, 20–26. [PubMed]
38. Sharifi-Rad, M.; Tayeboon, G.; Sharifi-Rad, J.; Iriti, M.; Varoni, E.; Razazi, S. Inhibitory activity on type 2 diabetes and hypertension key-enzymes, and antioxidant capacity of Veronica persica phenolic-rich extracts. Cell. Mol. Biol. 2016, 62, 80–85. [PubMed]
39. Sharifi-Rad, J.; Mnayer, D.; Roointan, A.; Shahri, F.; Ayatollahi, S.; Sharifi-Rad, M.; Molaee, N. Antibacterial activities of essential oils from Iranian medicinal plants on extended-spectrum β-lactamase-producing Escherichia coli. Cell. Mol. Biol. 2016, 62, 75–82. [PubMed]
40. Snow Setzer, M.; Sharifi-Rad, J.; Setzer, W.N. The search for herbal antibiotics: An in-silico investigation of antibacterial phytochemicals. Antibiotics 2016, 5, 30. [CrossRef] [PubMed]
41. Sharifi-Rad, M.; Mnayer, D.; Flaviana Bezerra Morais-Braga, M.; Nályda Pereira Carneiro, J.; Fonseca Bezerra, C.; Douglas Melo Coutinho, H.; Salehi, B.; Martorell, M.; del Mar Contreras, M.; Soltani-Nejad, A.; et al. Echinacea plants as antioxidant and antibacterial agents: From traditional medicine to biotechnological applications. Phytother. Res. 2018. [CrossRef] [PubMed]
42. Sharifi-Rad, M.; Varoni, E.M.; Iriti, M.; Martorell, M.; Setzer, W.N.; del Mar Contreras, M.; Salehi, B.; Soltani-Nejad, A.; Rajabi, S.; Tajbakhsh, M.; et al. Carvacrol and human health: A comprehensive review. Phytother. Res. 2018. [CrossRef] [PubMed]
43. Salehi, B.; Mishra, A.P.; Shukla, I.; Sharifi-Rad, M.; del Mar Contreras, M.; Segura-Carretero, A.; Fathi, H.; Nasri Nasrabadi, N.; Kobarfard, F.; Sharifi-Rad, J. Thymol, thyme and other plant sources: Health and potential uses. Phytother. Res. 2018. [CrossRef]
44. Sharifi-Rad, J.; Mnayer, D.; Tabanelli, G.; Stojanović-Radić, Z.; Sharifi-Rad, M.; Yousaf, Z.; Vallone, L.; Setzer, W.; Iriti, M. Plants of the genus Allium as antibacterial agents: From tradition to pharmacy. Cell. Mol. Biol. 2016, 62, 57–68. [PubMed]
45. Sharifi-Rad, M.; Iriti, M.; Gibbons, S.; Sharifi-Rad, J. Anti-methicillin-resistant Staphylococcus aureus (MRSA) activity of Rubiaceae, Fabaceae and Poaceae plants: A search for new sources of useful alternative antibacterials against MRSA infections. Cell. Mol. Biol. 2016, 62, 39–45. [PubMed]
46. Sharifi-Rad, J.; Soufi, L.; Ayatollahi, S.; Iriti, M.; Sharifi-Rad, M.; Varoni, E.M.; Shahri, F.; Esposito, S.; Kuhestani, K. Anti-bacterial effect of essential oil from Xanthium strumarium against shiga toxin-producing Escherichia coli. Cell. Mol. Biol. 2016, 62, 69–74. [PubMed]
47. Painter, G.; Almond, M.; Mao, S.; Liotta, D. Biochemical and mechanistic basis for the activity of nucleoside analogue inhibitors of HIV reverse transcriptase. Curr. Top. Med. Chem. 2004, 4, 1035–1044. [CrossRef] [PubMed]
48. Konvalinka, J.; Kräusslich, H.-G.; Müller, B. Retroviral proteases and their roles in virion maturation. Virology 2015, 479–480, 403–417. [CrossRef] [PubMed]
49. Blanco, J.L.; Whitlock, G.; Milinkovic, A.; Moyle, G. HIV integrase inhibitors: A new era in the treatment of HIV. Expert Opin. Pharmacother. 2015, 16, 1313–1324. [CrossRef] [PubMed]
50. Matthée, G.; Wright, A.D.; König, G.M. HIV reverse transcriptase inhibitors of natural origin. Planta Med. 1999, 65, 493–506. [CrossRef] [PubMed]
51. Yao, X.J.; Wainberg, M.A.; Parniak, M.A. Mechanism of inhibition of HIV-1 infection in vitro by purified extract of Prunella vulgaris. Virology 1992, 187, 56–62. [CrossRef]
52. Reddy, V.L.N.; Reddy, S.M.; Ravikanth, V.; Krishnaiah, P.; Goud, T.V.; Rao, T.P.; Ram, T.S.; Gonnade, R.G.; Bhadbhade, M.; Venkateswarlu, Y. A new BIS-andrographolide ether from Andrographis paniculata Nees and evaluation of anti-HIV activity. Nat. Prod. Res. 2005, 19, 223–230. [CrossRef] [PubMed]
53. Behbahani, M. Evaluation of anti-HIV-1 activity of a new iridoid glycoside isolated from Avicenna marina, in vitro. Int. Immunopharmacol. 2014, 23, 262–266. [CrossRef] [PubMed]
54. Rege, A.A.; Ambaye, R.Y.; Deshmukh, R.A. Evaluation of in vitro inhibitory effect of selected plants and Shilajit on HIV-reverse transcriptase. Indian J. Nat. Prod. Res. 2012, 3, 145–151.
55. Rege, A.A.; Chowdhary, A.S. Evaluation of mangrove plants as putative HIV-protease inhibitors. Indian Drugs 2013, 50, 41–44.
56. Sabde, S.; Bodiwala, H.S.; Karmase, A.; Deshpande, P.J.; Kaur, A.; Ahmed, N.; Chauthe, S.K.; Brahmbhatt, K.G.; Phadke, R.U.; Mitra, D.; et al. Anti-HIV activity of indian medicinal plants. J. Nat. Med. 2011, 65, 662–669. [CrossRef] [PubMed]
57. Woradulayapinij, W.; Soonthornchareonnon, N.; Wiwat, C. In vitro HIV type 1 reverse transcriptase inhibitory activities of Thai medicinal plants and Canna indica L. rhizomes. J. Ethnopharmacol. 2005, 101, 84–89. [CrossRef] [PubMed]
58. Silprasit, K.; Seetaha, S.; Pongsanarakul, P.; Hannongbua, S.; Choowongkomon, K. Anti-HIV-1 reverse transcriptase activities of hexane extracts from some Asian medicinal plants. J. Med. Plants Res. 2011, 5, 4194–4201.
59. Blignaut, E.; Patton, L.L.; Nittayananta, W.; Ramirez-Amador, V.; Ranganathan, K.; Chattopadhyay, A. (A3) HIV phenotypes, oral lesions, and management of HIV-related disease. Adv. Dent. Res. 2006, 19, 122–129. [CrossRef] [PubMed]
60. Lam, T.L.; Lam, M.L.; Au, T.K.; Ip, D.T.; Ng, T.B.; Fong, W.P.; Wan, D.C. A comparison of human immunodeficiency virus type-1 protease inhibition activities by the aqueous and methanol extracts of Chinese medicinal herbs. Life Sci. 2000, 67, 2889–2896. [CrossRef]
61. Bedoya, L.M.; Sanchez-Palomino, S.; Abad, M.J.; Bermejo, P.; Alcami, J. Anti-HIV activity of medicinal plant extracts. J. Ethnopharmacol. 2001, 77, 113–116. [CrossRef]
62. Grzybek, J.; Wongpanich, V.; Mata-Greenwood, E.; Angerhofer, C.K.; Pezzuto, J.M.; Cordell, G.A. Biological evaluation of selected plants from Poland. Pharm. Biol. 1997, 35, 1–5. [CrossRef]
63. Uncini Manganelli, R.E.; Zaccaro, L.; Tomei, P.E. Antiviral activity in vitro of Urtica dioica L., Parietaria diffusa M. et K. and Sambucus nigra L. J. Ethnopharmacol. 2005, 98, 323–327. [CrossRef] [PubMed]
64. Mlinarič, A.; Kreft, S.; Umek, A.; Štrukelj, B. Screening of selected plant extracts for in vitro inhibitory activity on HIV-1 reverse transcriptase (HIV-1 RT). Pharmazie 2000, 55, 75–77. [PubMed]
65. Ma, Y.M.; Wu, H. Chemical constituents of Sambucus L. Chin. J. Org. Chem. 2012, 32, 2063–2072. [CrossRef]
66. Chang, Y.S.; Woo, E.R. Korean medicinal plants inhibiting to human immunodeficiency virus type 1 (HIV-1) fusion. Phytother. Res. 2003, 17, 426–429. [CrossRef] [PubMed]
67. Kapewangolo, P.; Tawha, T.; Nawinda, T.; Knott, M.; Hans, R. Sceletium tortuosum demonstrates in vitro anti-HIV and free radical scavenging activity. S. Afr. J. Bot. 2016, 106, 140–143. [CrossRef]
68. Xu, H.-X.; Wan, M.; Loh, B.-N.; Kon, O.-L.; Chow, P.-W.; Sim, K.-Y. Screening of traditional medicines for their inhibitory activity against HIV-1 protease. Phytother. Res. 1996, 10, 207–210. [CrossRef]
69. Peng, Z.G.; Chen, H.S.; Guo, Z.M.; Dong, B.; Tian, G.Y.; Wang, G.Q. Anti-HIV activities of Achyranthes bidentata polysaccharide sulfate in vitro and in vivo. Yaoxue Xuebao 2008, 43, 702–706.
70. Gujjeti, R.P.; Mamidala, E. Anti-HIV activity of phytosterol isolated from Aerva lanata roots. Pharmacogn. J. 2017, 9, 112–116. [CrossRef]
71. Lagrota, M.H.C.; Wigg, M.D.; Santos, M.M.G.; Miranda, M.M.F.S.; Camara, F.P.; Couceiro, J.N.S.S.; Costa, S.S. Inhibitory activity of extracts of Alternanthera brasiliana (Amaranthaceae) against the herpes simplex virus. Phytother. Res. 1994, 8, 358–361. [CrossRef]
72. Chang, R.S.; Yeung, H.W. Inhibition of growth of human immunodeficiency virus in vitro by crude extracts of Chinese medicinal herbs. Antivir. Res. 1988, 9, 163–175. [CrossRef]
73. Zhang, S.M.; He, Y.S.; Tabba, H.D.; Smith, K.M. Inhibitor against the human immunodeficiency virus in aqueous extracts of Alternanthera philoxeroides. Chin. Med. J. 1988, 101, 861–866. [PubMed]
74. Ali, H.; Konig, G.M.; Khalid, S.A.; Wright, A.D.; Kaminsky, R. Evaluation of selected sudanese medicinal plants for their in vitro activity against hemoflagellates, selected bacteria, HIV-1-RT and tyrosine kinase inhibitory, and for cytotoxicity. J. Ethnopharmacol. 2002, 83, 219–228. [CrossRef]
75. Klos, M.; van de Venter, M.; Milne, P.J.; Traore, H.N.; Meyer, D.; Oosthuizen, V. In vitro anti-HIV activity of five selected South African medicinal plant extracts. J. Ethnopharm. 2009, 124, 182–188. [CrossRef] [PubMed]
76. Husson, G.P.; Subra, F.; Lai-Kuen, R.; Vilagines, R. Antiviral activity of hydroalcoholic extract from Haemanthus albiflos on the moloney murine leukemia virus and the human immunodeficiency virus. C. R. Seances Soc. Biol. Fil. 1997, 191, 473–485. [PubMed]
77. Szlavik, L.; Gyuris, A.; Minarovits, J.; Forgo, P.; Molnar, J.; Hohmann, J. Alkaloids from Leucojum vernum and antiretroviral activity of Amaryllidaceae alkaloids. Planta Med. 2004, 70, 871–873. [CrossRef] [PubMed]
78. Thamburan, S.; Klaasen, J.; Mabusela, W.T.; Cannon, J.F.; Folk, W.; Johnson, Q. Tulbaghia alliacea phytotherapy: A potential anti-infective remedy for candidiasis. Phytother. Res. 2006, 20, 844–850. [CrossRef] [PubMed]
79. Sigidi, M.T.; Traoré, A.N.; Boukandou, M.M.; Tshisikhawe, M.P.; Ntuli, S.S.; Potgieter, N. Anti-HIV, pro-inflammatory and cytotoxicity properties of selected Venda plants. Indian J. Tradit. Knowl. 2017, 16, 545–552.
80. Muanza, D.N.; Euler, K.L.; Williams, L.; Newman, D.J. Screening for antitumor and anti-HIV activities of nine medicinal plants from Zaire. Pharm. Biol. 1995, 33, 98–106. [CrossRef]
81. Djakpo, O.; Yao, W. Rhus chinensis and Galla chinensis—Folklore to modern evidence: Review. Phytother. Res. 2010, 24, 1739–1747. [CrossRef] [PubMed]
82. Abdel-Malek, S.; Bastien, J.W.; Mahler, W.F.; Jia, Q.; Reinecke, M.G.; Robinson, W.E.; Shu, Y.-H.; Zalles-Asin, J. Drug leads from the Kallawaya herbalists of Bolivia. 1. Background, rationale, protocol and anti-HIV activity. J. Ethnopharmacol. 1996, 50, 157–166. [CrossRef]
83. Kusumoto, I.T.; Nakabayashi, T.; Kida, H.; Miyashiro, H.; Hattori, M.; Namba, T.; Shimotohno, K. Screening of various plant-extracts used in ayurvedic medicine for inhibitory effects on human-immunodeficiency-virus type-1 (HIV-1) protease. Phytother. Res. 1995, 9, 180–184. [CrossRef]
84. McMahon, J.B.; Currens, M.J.; Gulakowski, R.J.; Buckheit, R.W., Jr.; Lackman-Smith, C.; Hallock, Y.F.; Boyd, M.R. Michellamine B, a novel plant alkaloid, inhibits human immunodeficiency virus-induced cell killing by at least two distinct mechanisms. Antimicrob. Agents Chemother. 1995, 39, 484–488. [CrossRef] [PubMed]
85. Thomas, D.W.; Boyd, M.R.; Cardellina, J.H.; Gereau, R.E.; Jato, J.; Symonds, P. Notes on economic plants. Econ. Bot. 1994, 48, 413–414. [CrossRef]
86. Bringmann, G.; Steinert, C.; Feineis, D.; Mudogo, V.; Betzin, J.; Scheller, C. HIV-inhibitory michellamine-type dimeric naphthylisoquinoline alkaloids from the central African liana Ancistrocladus congolensis. Phytochemistry 2016, 128, 71–81. [CrossRef] [PubMed]
87. Hien, N.T.T.; Nhiem, N.X.; Yen, D.T.H.; Hang, D.T.T.; Tai, B.H.; Quang, T.H.; Anh, H.L.T.; Van Kiem, P.; Van Minh, C.; Kim, E.J.; et al. Chemical constituents of the Annona glabra fruit and their cytotoxic activity. Pharm. Biol. 2015, 53, 1602–1607. [CrossRef] [PubMed]
88. Wu, Y.C.; Hung, Y.C.; Chang, F.R.; Cosentino, M.; Wang, H.K.; Lee, K.H. Identification of ent-16β,17-dihydroxykauran-19-oic acid as an anti-HIV principle and isolation of the new diterpenoids annosquamosins A and B from Annona squamosa. J. Nat. Prod. 1996, 59, 635–637. [CrossRef] [PubMed]
89. Yu, Z.X.; Niu, Z.G.; Li, X.B.; Zheng, C.J.; Song, X.M.; Chen, G.Y.; Song, X.P.; Han, C.R.; Wu, S.X. New phenylpropanoid and 6H-dibenzo(b,d)pyran-6-one derivatives from the stems of Dasymaschalon rostratum. Fitoterapia 2017, 118, 27–31. [CrossRef] [PubMed]
90. Hongthong, S.; Kuhakarn, C.; Jaipetch, T.; Prabpai, S.; Kongsaeree, P.; Piyachaturawat, P.; Jariyawat, S.; Suksen, K.; Limthongkul, J.; Panthong, A.; et al. Polyoxygenated cyclohexene derivatives isolated from Dasymaschalon sootepense and their biological activities. Fitoterapia 2015, 106, 158–166. [CrossRef] [PubMed]
91. Li, H.Y.; Sun, N.J.; Kashiwada, Y.; Sun, L.; Snider, J.V.; Cosentino, L.M.; Lee, K.H. Anti-AIDS agents, 9. Suberosol, a new C31 lanostane-type triterpene and anti-HIV principle from Polyalthia suberosa. J. Nat. Prod. 1993, 56, 1130–1133. [CrossRef] [PubMed]
92. Tuchinda, P.; Pohmakotr, M.; Reutrakul, V.; Thanyachareon, W.; Sophasan, S.; Yoosook, C.; Santisuk, T.; Pezzuto, J.M. 2-substituted furans from Polyalthia suberosa. Planta Med. 2001, 67, 572–575. [CrossRef] [PubMed]
93. Matsuse, I.T.; Lim, Y.A.; Hattori, M.; Correa, M.; Gupta, M.P. A search for anti-viral properties in Panamanian medicinal plants. J. Ethnopharmacol. 1998, 64, 15–22. [CrossRef]
94. Louvel, S.; Moodley, N.; Seibert, I.; Steenkamp, P.; Nthambeleni, R.; Vidal, V.; Maharaj, V.; Klimkait, T. Identification of compounds from the plant species Alepidea amatymbica active against HIV. S. Afr. J. Bot. 2013, 86, 9–14. [CrossRef]
95. Hussein, G.; Miyashiro, H.; Nakamura, N.; Hattori, M.; Kawahata, T.; Otake, T.; Kakiuchi, N.; Shimotohno, K. Inhibi HIV-1 protease. Phytother. Res. 1999, 13, 31–36. [CrossRef]
96. Min, B.S.; Bae, K.H.; Kim, Y.H.; Miyashiro, H.; Hattori, M.; Shimotohno, K. Screening of Korean plants against human immunodeficiency virus type 1 protease. Phytother. Res. 1999, 13, 680–682. [CrossRef]
97. Lee, T.T.Y.; Kashiwada, Y.; Huang, L.; Snider, J.; Cosentino, M.; Lee, K.H. Suksdorfin: An anti-HIV principle from Lomatium suksdorfii, its structure-activity correlation with related coumarins, and synergistic effects with anti-AIDS nucleosides. Bioorgan. Med. Chem. 1994, 2, 1051–1056. [CrossRef]
98. Bicchi, C.; Rubiolo, P.; Ballero, M.; Sanna, C.; Matteodo, M.; Esposito, F.; Zinzula, L.; Tramontano, E. HIV-1-inhibiting activity of the essential oil of Ridolfia segetum and Oenanthe crocata. Planta Med. 2009, 75, 1331–1335. [CrossRef] [PubMed]
99. Chingwaru, W.; Vidmar, J.; Kapewangolo, P.T. The potential of sub-Saharan African plants in the management of human immunodeficiency virus infections: A review. Phytother. Res. 2015, 29, 1452–1487. [CrossRef] [PubMed]
100. Esposito, F.; Mandrone, M.; Del Vecchio, C.; Carli, I.; Distinto, S.; Corona, A.; Lianza, M.; Piano, D.; Tacchini, M.; Maccioni, E.; et al. Multi-target activity of Hemidesmus indicus decoction against innovative HIV-1 drug targets and characterization of lupeol mode of action. Pathog. Dis. 2017, 75. [CrossRef] [PubMed]
101. Kapewangolo, P.; Knott, M.; Shithigona, R.E.K.; Uusiku, S.L.; Kandawa-Schulz, M. In vitro anti-HIV and antioxidant activity of Hoodia gordonii (Apocynaceae), a commercial plant product. BMC Complement. Altern. Med. 2016, 16, 411. [CrossRef] [PubMed]
102. Rukunga, G.M.; Kofi-Tsekpo, M.W.; Kurokawa, M.; Kageyama, S.; Mungai, G.M.; Muli, J.M.; Tolo, F.M.; Kibaya, R.M.; Muthaura, C.N.; Kanyara, J.N.; et al. Evaluation of the HIV-1 reverse transcriptase inhibitory properties of extracts from some medicinal plants in Kenya. Afr. J. Health Sci. 2002, 9, 81–90. [CrossRef] [PubMed]
103. Wei, Y.; Ma, C.-M.; Hattori, M. Anti-HIV protease triterpenoids from the acid hydrolysate of Panax ginseng. Phytochem. Lett. 2009, 2, 63–66. [CrossRef]
104. Zhang, H.; Lu, Z.; Tan, G.T.; Qiu, S.; Farnsworth, N.R.; Pezzuto, J.M.; Fong, H.H.S. Polyacetyleneginsenoside-Ro, a novel triterpene saponin from Panax ginseng. Tetrahedron Lett. 2002, 43, 973–977. [CrossRef]
105. Au, T.K.; Lam, T.L.; Ng, T.B.; Fong, W.P.; Wan, D.C.C. A Comparison of HIV-1 Integrase Inhibition by Aqueous and Methanol Extracts of Chinese Medicinal Herbs. Life Sci. 2001, 68, 1687–1694. [CrossRef]
106. Hasegawa, H.; Matsumiya, S.; Uchiyama, M.; Kurokawa, T.; Inouye, Y.; Kasai, R.; Ishibashi, S.; Yamasaki, K. Inhibitory effect of some triterpenoid saponins on glucose transport in tumor cells and its application to in vitro cytotoxic and antiviral activities. Planta Med. 1994, 60, 240–243. [CrossRef] [PubMed]
107. Wu, P.-L.; Su, G.-C.; Wu, T.-S. Constituents from the stems of Aristolochia manshuriensis. J. Nat. Prod. 2003, 66, 996–998. [CrossRef] [PubMed]
108. Salomón, H.; Pampuro, S.; Cavallaro, L.; García, G.; Coussio, J.; Campos, R. Anti-human immunodeficiency virus type 1 (HIV-1) activity of Achyrocline flaccida Wein DC and Gamochaeta simplicicaulis aqueous extracts. Phytother. Res. 1997, 11, 82–83. [CrossRef]
109. Sattar, E.A.; Galal, A.M.; Mossa, G.S. Antitumor germacranolides from Anvillea garcinii. J. Nat. Prod. 1996, 59, 403–405. [CrossRef] [PubMed]
110. Martinotti, E.; Calderone, V.; Breschi, M.C.; Bandini, P.; Cioni, P.L. Pharmacological action of aqueous crude extracts of Artemisia verlotorum Lamotte (Compositae). Phytother. Res. 1997, 11, 612–614. [CrossRef]
111. Cos, P.; Hermans, N.; De Bruyne, T.; Apers, S.; Sindambiwe, J.B.; Witvrouw, M.; De Clercq, E.; Vanden Berghe, D.; Pieters, L.; Vlietinck, A.J. Antiviral activity of Rwandan medicinal plants against human immunodeficiency virus type-1 (HIV-1). Phytomedicine 2002, 9, 62–68. [CrossRef] [PubMed]
112. Kato, T.; Horie, N.; Matsuta, T.; Naoki, U.; Shimoyama, T.; Kaneko, T.; Kanamoto, T.; Terakubo, S.; Nakashima, H.; Kusama, K.; et al. Anti-UV/HIV activity of kampo medicines and constituent plant extracts. In Vivo 2012, 26, 1007–1014. [PubMed]
113. Bunluepuech, K.; Tewtrakul, S. Anti-HIV-1 integrase activity of Thai medicinal plants in longevity preparations. Songklanakarin J. Sci. Technol. 2011, 33, 693–697.
114. Chukwujekwu, J.C.; Ndhlala, A.R.; de Kock, C.A.; Smith, P.J.; Van Staden, J. Antiplasmodial, HIV-1 reverse transcriptase inhibitory and cytotoxicity properties of Centratherum punctatum Cass. and its fractions. S. Afr. J. Bot. 2014, 90, 17–19. [CrossRef]
115. Muley, B.P.; Khadabadi, S.S.; Banarase, N.B. Phytochemical constituents and pharmacological activities of Calendula officinalis Linn (Asteraceae): A review. Trop. J. Pharm. Res. 2009, 8, 455–465. [CrossRef]
116. Wang, H.K.; Xia, Y.; Yang, Z.Y.; Morris Natschke, S.L.; Lee, K.H. Recent advances in the discovery and development of flavonoids and their analogues as antitumor and anti-HIV agents. Adv. Exp. Med. Biol. 1998, 439, 191–225. [PubMed]
117. Lee, J.S.; Kim, H.J.; Lee, Y.S. A new anti-HIV flavonoid glucuronide from Chrysanthemum morifolium. Planta Med. 2003, 69, 859–861. [PubMed]
118. Hu, C.-Q.; Chen, K.; Shi, Q.; Kilkuskie, R.E.; Cheng, Y.-C.; Lee, K.-H. Anti-AIDS agents, 10. Acacetin-7-o-β-D-galactopyranoside, an anti-HIV principle from Chrysanthemum morifolium and a structure-activity correlation with some related flavonoids. J. Nat. Prod. 1994, 57, 42–51. [CrossRef] [PubMed]
119. Tewtrakul, S.; Subhadhirasakul, S.; Cheenpracha, S.; Karalai, C. HIV-1 protease and HIV-1 integrase inhibitory substances from Eclipta prostrata. Phytother. Res. 2007, 21, 1092–1095. [CrossRef] [PubMed]
120. Tewtrakul, S.; Subhadhirasakul, S.; Kummee, S. Anti-HIV-1 integrase activity of medicinal plants used as self medication by AIDS patients. Songklanakarin J. Sci. Technol. 2006, 28, 785–790.
121. Ross, S.; El Sayed, K.; El Sohly, M.; Hamann, M.; Abdel-Halim, O.; Ahmed, A.; Ahmed, M. Phytochemical analysis of Geigeria alata and Francoeuria crispa essential oils. Planta Med. 1997, 63, 479–482. [CrossRef] [PubMed]
122. Hnatyszyn, O.; Broussalis, A.; Herrera, G.; Muschietti, L.; Coussio, J.; Martino, V.; Ferraro, G.; Font, M.; Monge, A.; Martínez-Irujo, J.J.; et al. Argentine plant extracts active against polymerase and ribonuclease h activities of HIV-1 reverse transcriptase. Phytother. Res. 1999, 13, 206–209. [CrossRef]
123. Heyman, H.M.; Senejoux, F.; Seibert, I.; Klimkait, T.; Maharaj, V.J.; Meyer, J.J.M. Identification of anti-HIV active dicaffeoylquinic- and tricaffeoylquinic acids in Helichrysum populifolium by NMR-based metabolomic guided fractionation. Fitoterapia 2015, 103, 155–164. [CrossRef] [PubMed]
124. Yu, Y.B.; Park, J.C.; Lee, J.H.; Kim, G.E.; Jo, S.K.; Byun, M.W.; Miyashiro, H.; Hattori, M. Screening of some plant extracts for inhibitory effects on HIV-1 and its essential enzymes. Korean J. Pharmacogn. 1998, 29, 338–346.
125. Fortin, H.; Tomasi, S.; Jaccard, P.; Robin, V.; Boustie, J. A prenyloxycoumarin from Psiadia dentata. Chem. Pharm. Bull. 2001, 49, 619–621. [CrossRef] [PubMed]
126. Kwon, H.C.; Jung, C.M.; Shin, C.G.; Lee, J.K.; Choi, S.U.; Kim, S.Y.; Lee, K.R. A new caffeoyl quinic acid from aster scaber and its inhibitory activity against human immunodeficiency virus-1 (HIV-1) integrase. Chem. Pharm. Bull. 2000, 48, 1796–1798. [CrossRef] [PubMed]
127. Ngwira, K.J.; Maharaj, V.J.; Mgani, Q.A. In vitro antiplasmodial and HIV-1 neutralization activities of root and leaf extracts from Berberis holstii. J. Herb. Med. 2015, 5, 30–35. [CrossRef]
128. Yu, Y.B.; Miyashiro, H.; Nakamura, N.; Hattori, M.; Jong, C.P. Effects of triterpenoids and flavonoids isolated from Alnus firma on HIV-1 viral enzymes. Arch. Pharm. Res. 2007, 30, 820–826. [CrossRef] [PubMed]
129. Niyonzima, G.; Laekeman, G.; Witvrouw, M.; Van Poel, B.; Pieters, L.; Paper, D.; De Clercq, E.; Franz, G.; Vlietinck, A.J. Hypoglycemic, anticomplement and anti-HIV activities of Spathodea campanulata stem bark. Phytomedicine 1999, 6, 45–49. [CrossRef]
130. Jain, M.; Kapadia, R.; Jadeja, R.N.; Thounaojam, M.C.; Devkar, R.V.; Mishra, S.H. Traditional uses, phytochemistry and pharmacology of Tecomella undulata—A review. Asian Pac. J. Trop. Biomed. 2012, 2, S1918–S1923. [CrossRef]
131. Yamasaki, K.; Otake, T.; Mori, H.; Morimoto, M.; Ueba, N.; Kurokawa, Y.; Shiota, K.; Yuge, T. Screening test of crude drug extract on anti-HIV activity. Yakugaku Zasshi 1993, 113, 818–824. [CrossRef] [PubMed]
132. Harnett, S.M.; Oosthuizen, V.; Van De Venter, M. Anti-HIV activities of organic and aqueous extracts of Sutherlandia frutescens and Lobostemon trigonus. J. Ethnopharmacol. 2005, 96, 113–119. [CrossRef] [PubMed]
133. Ye, X.; Ng, T.B. Isolation and characterization of juncin, an antifungal protein from seeds of Japanese takana (Brassica juncea var. Integrifolia). J. Agric. Food Chem. 2009, 57, 4366–4371. [CrossRef] [PubMed]
134. Jiang, Y.; Ng, T.B.; Wang, C.R.; Zhang, D.; Cheng, Z.H.; Liu, Z.K.; Qiao, W.T.; Geng, Y.Q.; Li, N.; Liu, F. Inhibitors from natural products to HIV-1 reverse transcriptase, protease and integrase. Mini-Rev. Med. Chem. 2010, 10, 1331–1344. [CrossRef] [PubMed]
135. Bedoya, L.M.; Beltrán, M.; Sancho, R.; Olmedo, D.A.; Sánchez-Palomino, S.; Del Olmo, E.; López-Pérez, J.L.; Muñoz, E.; San Feliciano, A.; Alcamí, J. 4-phenylcoumarins as HIV transcription inhibitors. Bioorgan. Med. Chem. Lett. 2005, 15, 4447–4450. [CrossRef] [PubMed]
136. Wang, Q.; Ding, Z.H.; Liu, J.K.; Zheng, Y.T. Xanthohumol, a novel anti-HIV-1 agent purified from Hops Humulus lupulus. Antivir. Res. 2004, 64, 189–194. [CrossRef]
137. Chang, C.W.; Lin, M.T.; Lee, S.S.; Liu, K.C.S.C.; Hsu, F.L.; Lin, J.Y. Differential inhibition of reverse transcriptase and cellular DNA polymerase-α activities by lignans isolated from Chinese herbs, Phyllanthus myrtifolius Moon, and tannins from Lonicera japonica Thunb and Castanopsis hystrix. Antivir. Res. 1995, 27, 367–374. [CrossRef]
138. Kashyap, K.; Sarkar, P.; Kalita, M.C.; Banu, S. A review on the widespread therapeutic application of the traditional herb Drymaria cordata. Int. J. Pharma Bio Sci. 2014, 5, P696–P705.
139. Hsieh, P.W.; Chang, F.R.; Lee, K.H.; Hwang, T.L.; Chang, S.M.; Wu, Y.C. A new anti-HIV alkaloid, drymaritin, and a new C-glycoside flavonoid, diandraflavone, from Drymaria diandra. J. Nat. Prod. 2004, 67, 1175–1177. [CrossRef] [PubMed]
140. Prinsloo, G.; Meyer, J.J.M.; Hussein, A.A.; Munoz, E.; Sanchez, R. A cardiac glucoside with in vitro anti-HIV activity isolated from Elaeodendron croceum. Nat. Prod. Res. 2010, 24, 1743–1746. [CrossRef] [PubMed]
141. Maregesi, S.M.; Hermans, N.; Dhooghe, L.; Cimanga, K.; Ferreira, D.; Pannecouque, C.; Berghe, D.A.V.; Cos, P.; Maes, L.; Vlietinck, A.J.; et al. Phytochemical and biological investigations of Elaeodendron schlechteranum. J. Ethnopharmacol. 2010, 129, 319–326. [CrossRef] [PubMed]
142. Kuo, Y.H.; Kuo, L.M.Y. Antitumour and anti-AIDS triterpenes from Celastrus hindsii. Phytochemistry 1997, 44, 1275–1281. [PubMed]
143. Tai, B.H.; Nhut, N.D.; Nhiem, N.X.; Quang, T.H.; Thanh Ngan, N.T.; Thuy Luyen, B.T.; Huong, T.T.; Wilson, J.; Beutler, J.A.; Ban, N.K.; et al. An evaluation of the RNase H inhibitory effects of Vietnamese medicinal plant extracts and natural compounds. Pharm. Biol. 2011, 49, 1046–1051. [CrossRef] [PubMed]
144. Piacente, S.; Dos Santos, L.C.; Mahmood, N.; Pizza, C. Triterpenes from Maytenus mWacrocarpa and evaluation of their anti-HIV activity. Nat. Prod. Commun. 2006, 1, 1073–1078.
145. Chen, K.; Shi, Q.; Kashiwada, Y.; Hu, C.Q.; Zhang, D.C.; Jin, J.Q.; Nozaki, H.; Kilkuskie, R.E.; Tramontano, E.; Cheng, Y.C.; et al. Anti-AIDS agents, 6. Salaspermic acid, an anti-HIV principle from Tripterycium wilfordii, and the structure-activity correlation with its related compounds. J. Nat. Prod. 1992, 55, 340–346. [CrossRef] [PubMed]
146. Chen, K.; Shi, Q.; Fujioka, T.; Zhang, D.-C.; Hu, C.-Q.; Jin, J.-Q.; Kilkuskie, R.E.; Lee, K.-H. Anti-AIDS agents, 4. Tripterifordin, a novel anti-HIV principle from Tripterygium wilfordii: Isolation and structural elucidation. J. Nat. Prod. 1992, 55, 88–92. [CrossRef] [PubMed]
147. Duan, H.; Takaishi, Y.; Imakura, Y.; Jia, Y.; Li, D.; Cosentino, L.M.; Lee, K.-H. Sesquiterpene alkaloids from Tripterygium hypoglaucum and Tripterygium wilfordii: A new class of potent anti-HIV agents. J. Nat. Prod. 2000, 63, 357–361. [CrossRef] [PubMed]
148. Chen, K.; Shi, Q.; Fujioka, T.; Nakano, T.; Hu, C.Q.; Jin, J.Q.; Kilkuskie, R.E.; Lee, K.H. Anti-AIDS agents-XIX. Neotripterifordin, a novel anti-HIV principle from Tripterygium wilfordii: Isolation and structural elucidation. Bioorgan. Med. Chem. 1995, 3, 1345–1348. [CrossRef]
149. Fang, P.L.; Cao, Y.L.; Yan, H.; Pan, L.L.; Liu, S.C.; Gong, N.B.; Lü, Y.; Chen, C.X.; Zhong, H.M.; Guo, Y.; et al. Lindenane disesquiterpenoids with anti-HIV-1 activity from Chloranthus japonicus. J. Nat. Prod. 2011, 74, 1408–1413. [CrossRef] [PubMed]
150. Yan, H.; Ba, M.Y.; Li, X.H.; Guo, J.M.; Qin, X.J.; He, L.; Zhang, Z.Q.; Guo, Y.; Liu, H.Y. Lindenane sesquiterpenoid dimers from Chloranthus japonicus inhibit HIV-1 and HCV replication. Fitoterapia 2016, 115, 64–68. [CrossRef] [PubMed]
151. Chattopadhyay, S.K.; Chatterjee, A.; Tandon, S.; Maulik, P.R.; Kant, R. Isolation of optically active nevirapine, a dipyridodiazepinone metabolite from the seeds of Cleome viscosa. Tetrahedron 2011, 67, 452–454. [CrossRef]
152. Fuller, R.W.; Blunt, J.W.; Boswell, J.L.; Cardellina, J.H.; Boyd, M.R. Guttiferone F, the first prenylated benzophenone from Allanblackia stuhlmannii. J. Nat. Prod. 1999, 62, 130–132. [CrossRef] [PubMed]
153. Huerta-Reyes, M.; Basualdo, M.D.C.; Lozada, L.; Jimenez-Estrada, M.; Soler, C.; Reyes-Chilpa, R. HIV-1 inhibition by extracts of Clusiaceae species from Mexico. Biol. Pharm. Bull. 2004, 27, 916–920. [CrossRef] [PubMed]
154. Huerta-Reyes, M.; Basualdo, M.D.C.; Abe, F.; Jimenez-Estrada, M.; Soler, C.; Reyes-Chilpa, R. HIV-1 inhibitory compounds from Calophyllum brasiliense leaves. Biol. Pharm. Bull. 2004, 27, 1471–1475. [CrossRef] [PubMed]
155. Gomez-Verjan, J.C.; Estrella-Parra, E.A.; Gonzalez-Sanchez, I.; Rivero-Segura, N.A.; Vazquez-Martinez, R.; Magos-Guerrero, G.; Mendoza-Villanueva, D.; Cerbón-Cervantes, M.A.; Reyes-Chilpa, R. Toxicogenomic analysis of pharmacological active coumarins isolated from Calophyllum brasiliense. Genom. Data 2015, 6, 258–259. [CrossRef] [PubMed]
156. Spino, C.; Dodier, M.; Sotheeswaran, S. Anti-HIV coumarins from Calophyllum seed oil. Bioorgan. Med. Chem. Lett. 1998, 8, 3475–3478. [CrossRef]
157. Dharmaratne, H.; Wanigasekera, W.; Mata-Greenwood, E.; Pezzuto, J. Inhibition of human immunodeficiency virus type 1 reverse transcriptase activity by cordatolides isolated from Calophyllum cordato-oblongum. Planta Med. 2007, 64, 460–461. [CrossRef] [PubMed]
158. Chaitra Narayan, L.; Ravishankar Rai, V.; Tewtrakul, S. A screening strategy for selection of anti-HIV-1 integrase and anti-HIV-1 protease inhibitors from extracts of Indian medicinal plants. Int. J. Phytomed. 2011, 3, 312–318.
159. Pawar, K.D.; Joshi, S.P.; Bhide, S.R.; Thengane, S.R. Pattern of anti-HIV dipyranocoumarin expression in callus cultures of Calophyllum inophyllum linn. J. Biotechnol. 2007, 130, 346–353. [CrossRef] [PubMed]
160. Laure, F.; Raharivelomanana, P.; Butaud, J.F.; Bianchini, J.P.; Gaydou, E.M. Screening of anti-HIV-1 inophyllums by HPLC-DAD of Calophyllum inophyllum leaf extracts from French Polynesia islands. Anal. Chim. Acta 2008, 624, 147–153. [CrossRef] [PubMed]
161. Currens, M.J.; Mariner, J.M.; McMahon, J.B.; Boyd, M.R. Kinetic analysis of inhibition of human immunodeficiency virus type-1 reverse transcriptase by calanolide a. J. Pharmacol. Exp. Ther. 1996, 279, 652–661. [PubMed]
162. Galinis, D.L.; Fuller, R.W.; McKee, T.C.; Cardellina, J.H.; Gulakowski, R.J.; McMahon, J.B.; Boyd, M.R. Structure−activity modifications of the HIV-1 inhibitors (+)-calanolide a and (−)-calanolide b1. J. Med. Chem. 1996, 39, 4507–4510. [CrossRef] [PubMed]
163. Kashman, Y.; Gustafson, K.R.; Fuller, R.; Cardellina, J., 2nd; McMahon, J.; Currens, M.; Buckheit, R., Jr.; Hughes, S.; Cragg, G.; Boyd, M. The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum. J. Med. Chem. 1992, 35, 2735–2743. [CrossRef] [PubMed]
164. McKee, T.C.; Fuller, R.W.; Covington, C.D.; Cardellina Ii, J.H.; Gulakowski, R.J.; Krepps, B.L.; McMahon, J.B.; Boyd, M.R. New pyranocoumarins isolated from Calophyllum lanigerum and Calophyllum teysmannii. J. Nat. Prod. 1996, 59, 754–758. [CrossRef] [PubMed]
165. Alkhamaiseh, S.I.; Taher, M.; Ahmad, F. The phytochemical contents and antimicrobial activities of Malaysian Calophyllum rubiginosum. Am. J. Appl. Sci. 2011, 8, 201–205. [CrossRef]
166. Magadula, J.J.; Tewtrakul, S. Anti-HIV-1 protease activities of crude extracts of some Garcinia species growing in Tanzania. Afr. J. Biotechnol. 2010, 9, 1848–1852.
167. Zhou, P.; Takaishi, Y.; Duan, H.; Chen, B.; Honda, G.; Itoh, M.; Takeda, Y.; Kodzhimatov, O.K.; Lee, K.H. Coumarins and bicoumarin from Ferula sumbul: Anti-HIV activity and inhibition of cytokine release. Phytochemistry 2000, 53, 689–697. [CrossRef]
168. Magadula, J.J.; Suleimani, H.O. Cytotoxic and anti-HIV activities of some Tanzanian Garcinia species. Tanzania J. Health Res. 2010, 12. [CrossRef]
169. Chen, S.X.; Wan, M.; Loh, B.N. Active constituents against HIV-1 protease from Garcinia mangostana. Planta Med. 1996, 62, 381–382. [CrossRef] [PubMed]
170. Rimando, A.M.; Pezzuto, J.M.; Farnsworth, N.R.; Santisuk, T.; Reutrakul, V.; Kawanishi, K. New lignans from Anogeissus acuminata with HIV-1 reverse transcriptase inhibitory activity. J. Nat. Prod. 1994, 57, 896–904. [CrossRef] [PubMed]
171. Mushi, N.F.; Mbwambo, Z.H.; Innocent, E.; Tewtrakul, S. Antibacterial, anti-HIV-1 protease and cytotoxic activities of aqueous ethanolic extracts from Combretum adenogonium Steud. Ex A. Rich (Combretaceae). BMC Complement. Altern. Med. 2012, 12. [CrossRef] [PubMed]
172. Bessong, P.O.; Obi, C.L.; Andréola, M.L.; Rojas, L.B.; Pouységu, L.; Igumbor, E.; Meyer, J.J.M.; Quideau, S.; Litvak, S. Evaluation of selected south african medicinal plants for inhibitory properties against human immunodeficiency virus type 1 reverse transcriptase and integrase. J. Ethnopharmacol. 2005, 99, 83–91. [CrossRef] [PubMed]
173. Asres, K.; Bucar, F. Anti-HIV activity against immunodeficiency virus type 1 (HIV-I) and type II (HIV-II) of compounds isolated from the stem bark of Combtetum molle. Ethiop. Med. J. 2005, 43, 15–20. [PubMed]
174. Asres, K.; Bucar, F.; Kartnig, T.; Witvrouw, M.; Pannecouque, C.; De Clercq, E. Antiviral activity against human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) of ethnobotanically selected Ethiopian medicinal plants. Phytother. Res. 2001, 15, 62–69. [CrossRef]
175. El-Mekkawy, S.; Meselhy, M.R.; Kusumoto, I.T.; Kadota, S.; Hattori, M.; Namba, T. Inhibitory effects of Egyptian folk medicines on human immunodeficiency virus (HIV) reverse transcriptase. Chem. Pharm. Bull. 1995, 43, 641–648. [CrossRef] [PubMed]
176. Valsaraj, R.; Pushpangadan, P.; Smitt, U.W.; Adsersen, A.; Christensen, S.B.; Sittie, A.; Nyman, U.; Nielsen, C.; Olsen, C.E. New anti-HIV-1, antimalarial, and antifungal compounds from Terminalia bellerica. J. Nat. Prod. 1997, 60, 739–742. [CrossRef] [PubMed]
177. Ahn, M.J.; Chul, Y.K.; Ji, S.L.; Tae, G.K.; Seung, H.K.; Lee, C.K.; Lee, B.B.; Shin, C.G.; Huh, H.; Kim, J. Inhibition of HIV-1 integrase by galloyl glucoses from Terminalia chebula and flavonol glycoside gallates from Euphorbia pekinensis. Planta Med. 2002, 68, 457–459. [CrossRef] [PubMed]
178. Chauke, M.A.; Shai, L.J.; Mogale, M.A.; Mokgotho, M.P. Antibacterial and anti HIV 1 reverse transcriptase activity of selected medicinal plants from Phalaborwa, South Africa. Res. J. Med. Plant 2016, 10, 388–395.
179. Tshikalange, T.E.; Meyer, J.J.M.; Lall, N.; Muñoz, E.; Sancho, R.; Van de Venter, M.; Oosthuizen, V. In vitro anti-HIV-1 properties of ethnobotanically selected South African plants used in the treatment of sexually transmitted diseases. J. Ethnopharmacol. 2008, 119, 478–481. [CrossRef] [PubMed]
180. Schröder, H.C.; Merz, H.; Steffen, R.; Müller, W.E.G.; Sarin, P.S.; Trumm, S.; Schulz, J.; Eich, E. Differential in vitro anti-HIV activity of natural lignans. Z. Naturforsch. C 1990, 45, 1215–1221. [PubMed]
181. Yamamoto, T.; Takahashi, H.; Sakai, K.; Kowithayakorn, T.; Koyano, T. Screening of Thai plants for anti-HIV-1 activity. Nat. Med. 1997, 51, 541–546.
182. Anonymous. Rubitecan: 9-NC, 9-Nitro-20(S)-Camptothecin, 9-Nitro-Camptothecin, 9-Nitrocamptothecin, RFS 2000, RFS2000. Drugs R D 2004, 5, 305–311.
183. Ju Gwon, P.; Jong Cheol, P.; Jong Moon, H.; Sung Jong, P.; Da Rae, C.; Dong Young, S.; Ky Young, P.; Hyun Wook, C.; Moon Sung, K. Phenolic compounds from Orostachys japonicus having anti-HIV-1 protease activity. Nat. Prod. Sci. 2000, 6, 117–121.
184. Okoye, E.L.; Nworu, C.S.; Ezeifeka, G.O.; Esimone, C.O. Inhibition of HIV-1 lentiviral particles infectivity by Gynostemma pentaphyllum extracts in a viral vectorbased assay. Afr. J. Biotechnol. 2012, 11, 1782–1788. [CrossRef]
185. Chen, J.C.; Zhang, G.H.; Zhang, Z.Q.; Qiu, M.H.; Zheng, Y.T.; Yang, L.M.; Yu, K.B. Octanorcucurbitane and cucurbitane triterpenoids from the tubers of Hemsleya endecaphylla with HIV-1 inhibitory activity. J. Nat. Prod. 2008, 71, 153–155. [CrossRef] [PubMed]
186. Thakur, G.S.; Bag, M.; Sanodiya, B.S.; Bhadauriya, P.; Debnath, M.; Prasad, G.B.K.S.; Bisen, P.S. Momordica balsamina: A medicinal and neutraceutical plant for health care management. Curr. Pharm. Biotechnol. 2009, 10, 667–682. [CrossRef] [PubMed]
187. Lee-Huang, S.; Huang, P.L.; Nara, P.L.; Chen, H.-C.; Kung, H.-F.; Huang, P.; Huang, H.I.; Huang, P.L. A new class of anti-HIV agents: GAP31, DAPs 30 and 32. FEBS Lett. 1990, 272, 12–18. [CrossRef]
188. Lee-Huang, S.; Huang, P.L.; Kung, H.F.; Li, B.Q.; Huang, P.L.; Huang, P.; Huang, H.I.; Chen, H.C. Tap 29: An anti-human immunodeficiency virus protein from Trichosanthes kirilowii that is nontoxic to intact cells. Proc. Natl. Acad. Sci. USA 1991, 88, 6570–6574. [CrossRef] [PubMed]
189. Amouroux, P.; Jean, D.; Lamaison, J.L. Antiviral activity in vitro of Cupressus sempervirens on two human retroviruses HIV and htlv. Phytother. Res. 1998, 12, 367–368. [CrossRef]
190. Offergeld, R.; Reinecker, C.; Gumz, E.; Schrum, S.; Treiber, R.; Neth, R.D.; Gohla, S.H. Mitogenic activity of high molecular polysaccharide fractions isolated from the Cuppressaceae Thuja occidentalis L. Enhanced cytokine-production by thyapolysaccharide, g-fraction (TPSg). Leukemia 1992, 6 (Suppl. 3), 189S–191S. [PubMed]
191. Chaniad, P.; Wattanapiromsakul, C.; Pianwanit, S.; Tewtrakul, S. Anti-HIV-1 integrase compounds from Dioscorea bulbifera and molecular docking study. Pharm. Biol. 2016, 54, 1077–1085. [CrossRef] [PubMed]
192. Meragelman, K.M.; McKee, T.C.; Boyd, M.R. Anti-HIV prenylated flavonoids from Monotes africanus. J. Nat. Prod. 2001, 64, 546–548. [CrossRef] [PubMed]
193. Min, B.S.; Tomiyama, M.; Ma, C.M.; Nakamura, N.; Hattori, M. Kaempferol acetylrhamnosides from the rhizome of Dryopteris crassirhizoma and their inhibitory effects on three different activities of human immunodeficiency virus-1 reverse transcriptase. Chem. Pharm. Bull. 2001, 49, 546–550. [CrossRef] [PubMed]
194. Lee, J.S.; Miyashiro, H.; Nakamura, N.; Hattori, M. Two new triterpenes from the rhizome of Dryopteris crassirhizoma, and inhibitory activities of its constituents on human immunodeficiency virus-1 protease. Chem. Pharm. Bull. 2008, 56, 711–714. [CrossRef] [PubMed]
195. Mahapatra, A.; Tshikalange, T.E.; Meyer, J.J.M.; Lall, N. Synthesis and HIV-1 reverse transcriptase inhibition activity of 1,4-naphthoquinone derivatives. Chem. Nat. Compd. 2012, 47, 883–887. [CrossRef]
196. Lee, S.-A.; Hong, S.-K.; Suh, C.-I.; Oh, M.-H.; Park, J.-H.; Choi, B.-W.; Park, S.-W.; Paik, S.-Y. Anti-HIV-1 efficacy of extracts from medicinal plants. J. Microbiol. 2010, 48, 249–252. [CrossRef] [PubMed]
197. El-Mekkawy, S.; Meselhy, M.R.; Nakamura, N.; Hattori, M.; Kawahata, T.; Otake, T. Anti-HIV-1 phorbol esters from the seeds of Croton tiglium. Phytochemistry 2000, 53, 457–464. [CrossRef]
198. Ayatollahi, A.M.; Zarei, S.M.; Memarnejadian, A.; Ghanadian, M.; Moghadam, M.H.; Kobarfard, F. Triterpene constituents of Euphorbia erythradenia Bioss. And their anti-HIV activity. Iran. J. Pharm. Res. 2016, 15, 19–27. [PubMed]
199. Zheng, W.; Cui, Z.; Zhu, Q. Cytotoxicity and antiviral activity of the compounds from Euphorbia kansui. Planta Med. 2007, 64, 754–756. [CrossRef] [PubMed]
200. Zhao, J.X.; Liu, C.P.; Qi, W.Y.; Han, M.L.; Han, Y.S.; Wainberg, M.A.; Yue, J.M. Eurifoloids A-R, structurally diverse diterpenoids from Euphorbia Neriifolia. J. Nat. Prod. 2014, 77, 2224–2233. [CrossRef] [PubMed]
201. Yan, S.L.; Li, Y.H.; Chen, X.Q.; Liu, D.; Chen, C.H.; Li, R.T. Diterpenes from the stem bark of Euphorbia neriifolia and their in vitro anti-HIV activity. Phytochemistry 2018, 145, 40–47. [CrossRef] [PubMed]
202. Cox, P.A. Saving the ethnopharmacological heritage of Samoa. J. Ethnopharmacol. 1993, 38, 181–188. [CrossRef]
203. Arisawa, M. A review of the biological activity and chemistry of Mallotus japonicus (Euphorbiaceae). Phytomedicine 1994, 1, 261–269. [CrossRef]
204. Pengsuparp, T.; Cai, L.; Constant, H.; Fong, H.H.S.; Lin, L.Z.; Kinghorn, A.D.; Pezzuto, J.M.; Cordell, G.A.; Ingolfsdóttir, K.; Wagner, H.; et al. Mechanistic evaluation of new plant-derived compounds that inhibit HIV-1 reverse transcriptase. J. Nat. Prod. 1995, 58, 1024–1031. [CrossRef] [PubMed]
205. Pengsuparp, T.; Cai, L.; Fong, H.H.S.; Kinghorn, A.D.; Pezzuto, J.M.; Wani, M.C.; Wall, M.E. Pentacyclic triterpenes derived from Maprounea africana are potent inhibitors of HIV-1 reverse transcriptase. J. Nat. Prod. 1994, 57, 415–418. [CrossRef] [PubMed]
206. Wang, H.X.; Ng, T.B. Examination of lectins, polysaccharopeptide, polysaccharide, alkaloid, coumarin and trypsin inhibitors for inhibitory activity against human immunodeficiency virus reverse transcriptase and glycohydrolases. Planta Med. 2001, 67, 669–672. [CrossRef] [PubMed]
207. Ranki, A.; Nyberg, M.; Ovod, V.; Haltia, M.; Elovaara, I.; Raininko, R.; Haapasalo, H.; Krohn, K. Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS 1995, 9, 1001–1008. [CrossRef] [PubMed]
208. Zhang, L.; Luo, R.-H.; Wang, F.; Jiang, M.-Y.; Dong, Z.-J.; Yang, L.-M.; Zheng, Y.-T.; Liu, J.-K. Highly functionalized daphnane diterpenoids from Trigonostemon thyrsoideum. Organ. Lett. 2010, 12, 152–155. [CrossRef] [PubMed]
209. Cheng, Y.-Y.; Chen, H.; He, H.-P.; Zhang, Y.; Li, S.-F.; Tang, G.-H.; Guo, L.-L.; Yang, W.; Zhu, F.; Zheng, Y.-T.; et al. Anti-HIV active daphnane diterpenoids from Trigonostemon thyrsoideum. Phytochemistry 2013, 96, 360–369. [CrossRef] [PubMed]
210. Ma, C.-M.; Nakamura, N.; Hattori, M. Saponins and C-glycosyl flavones from the seeds of Abrus precatorius. Chem. Pharm. Bull. 1998, 46, 982–987. [CrossRef]
211. Chinsembu, K.C. Ethnobotanical study of plants used in the management of HIV/AIDS-related diseases in Livingstone, Southern Province, Zambia. J. Evid.-Based Complement. Altern. Med. 2016, 2016, 4238625. [CrossRef] [PubMed]
212. Nutan, S.K.; Modi, M.; Dezzutti, C.S.; Kulshreshtha, S.; Rawat, A.K.S.; Srivastava, S.K.; Malhotra, S.; Verma, A.; Ranga, U.; Gupta, S.K. Extracts from Acacia catechu suppress HIV-1 replication by inhibiting the activities of the viral protease and tat. J. Virol. 2013, 10, 309. [CrossRef] [PubMed]
213. Abdallah, R.M.; Ghazy, N.M.; El-Sebakhy, N.; Pirillo, A.; Verotta, L. Astragalosides from Egyptian Astragalus spinosus Vahl. Pharmazie 1993, 48, 452–454. [PubMed]
214. Taylor, D.L.; Nash, R.; Fellows, L.E.; Kang, M.S.; Tyms, A.S. Naturally occurring pyrrolizidines: Inhibition of α-glucosidase 1 and anti-HIV activity of one steroisomer. Antivir. Chem. Chemother. 1992, 3, 273–277. [CrossRef]
215. Mahmood, N.; Pizza, C.; Aquino, R.; De Tommasi, N.; Piacente, S.; Colman, S.; Burke, A.; Hay, A.J. Inhibition of HIV infection by flavanoids. Antivir. Res. 1993, 22, 189–199. [CrossRef]
216. Mohammed, M.M.D.; Ibrahim, N.A.; Awad, N.E.; Matloub, A.A.; Mohamed-Ali, A.G.; Barakat, E.E.; Mohamed, A.E.; Colla, P.L. Anti-HIV-1 and cytotoxicity of the alkaloids of Erythrina abyssinica Lam. growing in Sudan. Nat. Prod. Res. 2012, 26, 1565–1575. [CrossRef] [PubMed]
217. Lee, J.; Oh, W.K.; Ahn, J.S.; Kim, Y.H.; Mbafor, J.T.; Wandji, J.; Fomum, Z.T. Prenylisoflavonoids from Erythrina senegalensis as novel HIV-1 protease inhibitors. Planta Med. 2009, 75, 268–270. [CrossRef] [PubMed]
218. Lo, W.L.; Wu, C.C.; Chang, F.R.; Wang, W.Y.; Khalil, A.T.; Lee, K.H.; Wu, Y.C. Antiplatelet and anti-HIV constituents from Euchresta formosana. Nat. Prod. Res. 2003, 17, 91–97. [CrossRef] [PubMed]
219. Konoshima, T.; Yasuda, I.; Kashiwada, Y.; Cosentino, L.M.; Lee, K.-H. Anti-AIDS agents, 21. Triterpenoid saponins as anti-HIV principles from fruits of Gleditsia japonica and Gymnocladus chinesis, and a structure-activity correlation. J. Nat. Prod. 1995, 58, 1372–1377. [CrossRef] [PubMed]
220. Cheng, B.H.; Zhou, X.; Wang, Y.; Chan, J.Y.W.; Lin, H.Q.; Or, P.M.Y.; Wan, D.C.C.; Leung, P.C.; Fung, K.P.; Wang, Y.F.; et al. Herb-drug interaction between an anti-HIV Chinese herbal sh formula and atazanavir in vitro and in vivo. J. Ethnopharmacol. 2015, 162, 369–376. [CrossRef] [PubMed]
221. Ito, M.; Sato, A.; Hirabayashi, K.; Tanabe, F.; Shigeta, S.; Baba, M.; De Clercq, E.; Nakashima, H.; Yamamoto, N. Mechanism of inhibitory effect of glycyrrhizin on replication of human immunodeficiency virus(HIV). Antivir. Res. 1988, 10, 289–298. [CrossRef]
222. Baltina, L.A. Chemical modification of glycyrrhizic acid as a route to new bioactive compounds for medicine. Curr. Med. Chem. 2003, 10, 155–171. [CrossRef] [PubMed]
223. Takada, K.; Bermingham, A.; O’Keefe, B.R.; Wamiru, A.; Beutler, J.A.; Le Grice, S.F.J.; Lloyd, J.; Gustafson, K.R.; McMahon, J.B. An HIV RNAse H inhibitory 1,3,4,5-tetragalloylapiitol from the African plant Hylodendron gabunensis. J. Nat. Prod. 2007, 70, 1647–1649. [CrossRef] [PubMed]
224. Likhitwitayawuid, K.; Sritularak, B.; Benchanak, K.; Lipipun, V.; Mathew, J.; Schinazi, R.F. Phenolics with antiviral activity from Millettia erythrocalyx and Artocarpus lakoocha. Nat. Prod. Res. 2005, 19, 177–182. [CrossRef] [PubMed]
225. Theo, A.; Masebe, T.; Suzuki, Y.; Kikuchi, H.; Wada, S.; Obi, C.L.; Bessong, P.O.; Usuzawa, M.; Oshima, Y.; Hattori, T. Peltophorum africanum, a traditional South African medicinal plant, contains an anti HIV-1 constituent, betulinic acid. Tohoku J. Exp. Med. 2009, 217, 93–99. [CrossRef] [PubMed]
226. Fang, E.F.; Lin, P.; Wong, J.H.; Tsao, S.W.; Ng, T.B. A lectin with anti-HIV-1 reverse transcriptase, antitumor, and nitric oxide inducing activities from seeds of Phaseolus vulgaris cv. extralong autumn purple bean. J. Agric. Food Chem. 2010, 58, 2221–2229. [CrossRef] [PubMed]
227. Li, L.; Li, X.; Shi, C.; Deng, Z.; Fu, H.; Proksch, P.; Lin, W. Pongamone A-E, five flavonoids from the stems of a mangrove plant, Pongamia pinnata. Phytochemistry 2006, 67, 1347–1352. [CrossRef] [PubMed]
228. Kashiwada, Y.; Wang, H.-K.; Nagao, T.; Kitanaka, S.; Yasuda, I.; Fujioka, T.; Yamagishi, T.; Cosentino, L.M.; Kozuka, M.; Okabe, H.; et al. Anti-AIDS agents. 30. Anti-HIV activity of oleanolic acid, pomolic acid, and structurally related triterpenoids. J. Nat. Prod. 1998, 61, 1090–1095. [CrossRef] [PubMed]
229. Thayil Seema, M.; Thyagarajan, S.P. Methanol and aqueous extracts of Ocimum kilimandscharicum (Karpuratulasi) inhibits HIV-1 reverse transcriptase in vitro. Int. J. Pharmacogn. Phytochem. Res. 2016, 8, 1099–1103.
230. Behbahani, M.; Sayedipour, S.; Pourazar, A.; Shanehsazzadeh, M. In vitro anti-HIV-1 activities of kaempferol and kaempferol-7-O-glucoside isolated from Securigera securidaca. Res. Pharm. Sci. 2014, 9, 463–469. [PubMed]
231. Quintero, A.; Fabbro, R.; Maillo, M.; Barrios, M.; Milano, M.B.; Fernandez, A.; Williams, B.; Michelangeli, F.; Rangel, H.R.; Pujol, F.H. Inhibition of hepatitis B virus and human immunodeficiency virus (HIV-1) replication by Warscewiczia coccinea (Vahl) Kl. (Rubiaceae) ethanol extract. Nat. Prod. Res. 2011, 25, 1565–1569. [CrossRef] [PubMed]
232. Dong, M.; Quan, L.Q.; Dai, W.F.; Yan, S.L.; Chen, C.H.; Chen, X.Q.; Li, R.T. Anti-inflammatory and anti-HIV compounds from Swertia bimaculata. Planta Med. 2017, 83, 1368–1373. [CrossRef] [PubMed]
233. Wang, J.-N.; Hou, C.-Y.; Liu, Y.-L.; Lin, L.-Z.; Gil, R.R.; Cordell, G.A. Swertifrancheside, an HIV-reverse transcriptase inhibitor and the first flavone-xanthone dimer, from Swertia franchetiana. J. Nat. Prod. 1994, 57, 211–217. [CrossRef] [PubMed]
234. Du, X.G.; Wang, W.; Zhang, Q.Y.; Cheng, J.; Avula, B.; Khan, I.A.; Guo, D.A. Identification of xanthones from Swertia punicea using high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2012, 26, 2913–2923. [CrossRef] [PubMed]
235. Chang, C.-C.; Lin, C.-N.; Lin, J.-Y. Inhibition of Moloney murine leukemia virus reverse transcriptase activity by tetrahydroxyxanthones isolated from the Chinese herb, Tripterospermum lanceolatum (Hyata). Antivir. Res. 1992, 19, 119–127. [CrossRef]
236. Ji, S.L.; Hattori, M.; Kim, J. Inhibition of HIV-1 protease and RNase H of HIV-1 reverse transcriptase activities by long chain phenols from the sarcotestas of Ginkgo biloba. Planta Med. 2008, 74, 532–534.
237. Lü, J.M.; Yan, S.; Jamaluddin, S.; Weakley, S.M.; Liang, Z.; Siwak, E.B.; Yao, Q.; Chen, C. Ginkgolic acid inhibits HIV protease activity and HIV infection in vitro. Med. Sci. Monit. 2012, 18, BR293–BR298. [CrossRef] [PubMed]
238. Rowley, D.C.; Hansen, M.S.; Rhodes, D.; Sotriffer, C.A.; Ni, H.; McCammon, J.A.; Bushman, F.D.; Fenical, W. Thalassiolins A-C: New marine-derived inhibitors of HIV cDNA integrase. Bioorgan. Med. Chem. 2002, 10, 3619–3625. [CrossRef]
239. Reutrakul, V.; Chanakul, W.; Pohmakotr, M.; Jaipetch, T.; Yoosook, C.; Kasisit, J.; Napaswat, C.; Santisuk, T.; Prabpai, S.; Kongsaeree, P.; et al. Anti-HIV-1 constituents from leaves and twigs of Cratoxylum arborescens. Planta Med. 2006, 72, 1433–1435. [CrossRef] [PubMed]
240. Sokmen, A.; Jones, B.M.; Erturk, M. Antimicrobial activity of extracts from the cell cultures of some Turkish medicinal plants. Phytother. Res. 1999, 13, 355–357. [CrossRef]
241. Esposito, F.; Sanna, C.; Del Vecchio, C.; Cannas, V.; Venditti, A.; Corona, A.; Bianco, A.; Serrilli, A.M.; Guarcini, L.; Parolin, C.; et al. Hypericum hircinum L. components as new single-molecule inhibitors of both HIV-1 reverse transcriptase-associated DNA polymerase and ribonuclease H activities. Pathog. Dis. 2013, 68, 116–124. [CrossRef] [PubMed]
242. Birt, D.F.; Widrlechner, M.P.; Hammer, K.D.P.; Hillwig, M.L.; Wei, J.; Kraus, G.A.; Murphy, P.A.; McCoy, J.A.; Wurtele, E.S.; Neighbors, J.D.; et al. Hypericum in infection: Identification of anti-viral and anti-inflammatory constituents. Pharm. Biol. 2009, 47, 774–782. [CrossRef] [PubMed]
243. Fuller, R.W.; Westergaard, C.K.; Collins, J.W.; Cardellina, J.H.; Boyd, M.R. Vismiaphenones D−G, new prenylated benzophenones from Vismia cayennensis. J. Nat. Prod. 1999, 62, 67–69. [CrossRef] [PubMed]
244. Drewes, S.E.; Khan, F. The African potato (Hypoxis hemerocallidea): A chemical-historical perspective. S. Afr. J. Sci. 2004, 100, 425–430.
245. Hara, H.; Maruyama, N.; Yamashita, S.; Hayashi, Y.; Lee, K.H.; Bastow, K.F.; Chairul; Marumoto, R.; Imakura, Y. Elecanacin, a novel new naphthoquinone from the bulb of Eleutherine americana. Chem. Pharm. Bull. 1997, 45, 1714–1716. [CrossRef]
246. Byung, S.M.; Hyeong, K.L.; Sang, M.L.; Young, H.K.; Ki, H.B.; Otake, T.; Nakamura, N.; Hattori, M. Anti-human immunodeficiency virus-type 1 activity of constituents from Juglans mandshurica. Arch. Pharm. Res. 2002, 25, 441–445.
247. Kim, H.K.; Lee, H.K.; Shin, C.G.; Huh, H. HIV integrase inhibitory activity of Agastache rugosa. Arch. Pharm. Res. 1999, 22, 520–523. [CrossRef] [PubMed]
248. Tang, X.; Chen, H.; Zhang, X.; Quan, K.; Sun, M. Screening anti-HIV Chinese materia medica with HIV and equine infectious anemic virus reverse transcriptase. J. Tradit. Chin. Med. 1994, 14, 10–13. [PubMed]
249. Shahidul Alam, M.; Quader, M.A.; Rashid, M.A. HIV-inhibitory diterpenoid from Anisomeles indica. Fitoterapia 2000, 71, 574–576. [CrossRef]
250. Bodiwala, H.S.; Sabde, S.; Mitra, D.; Bhutani, K.K.; Singh, I.P. Anti-HIV diterpenes from Coleus forskohlii. Nat. Prod. Commun. 2009, 4, 1173–1175. [PubMed]
251. Kreis, W.; Kaplan, M.H.; Freeman, J.; Sun, D.K.; Sarin, P.S. Inhibition of HIV replication by Hyssop officinalis extracts. Antivir. Res. 1990, 14, 323–337. [CrossRef]
252. Miraj, S.; Azizi, N.; Kiani, S. A review of chemical components and pharmacological effects of Melissa officinalis L. Der Pharm. Lett. 2016, 8, 229–237.
253. Amzazi, S.; Ghoulami, S.; Bakri, Y.; Il Idrissi, A.; Fkih-Tétouani, S.; Benjouad, A. Human immunodeficiency virus type 1 inhibitory activity of Mentha longifolia. Thérapie 2003, 58, 531–534. [CrossRef] [PubMed]
254. Behbahani, M.; Mohabatkar, H.; Soltani, M. Anti-HIV-1 activities of aerial parts of Ocimum basilicum and its parasite Cuscuta campestris. J. Antivir. Antiretrovir. 2013, 5, 57–61. [CrossRef]
255. Kapewangolo, P.; Omolo, J.; Fonteh, P.; Kandawa-Schulz, M.; Meyer, D. Triterpenoids from Ocimum labiatum activates latent HIV-1 expression in vitro: Potential for use in adjuvant therapy. Molecules 2017, 22, 1703. [CrossRef] [PubMed]
256. Kapewangolo, P.; Hussein, A.A.; Meyer, D. Inhibition of HIV-1 enzymes, antioxidant and anti-inflammatory activities of Plectranthus barbatus. J. Ethnopharmacol. 2013, 149, 184–190. [CrossRef] [PubMed]
257. Tabba, H.D.; Chang, R.S.; Smith, K.M. Isolation, purification, and partial characterization of prunellin, an anti-HIV component from aqueous extracts of Prunella vulgaris. Antivir. Res. 1989, 11, 263–273. [CrossRef]
258. Pariš, A.; Štrukelj, B.; Renko, M.; Turk, V.; Pukl, M.; Umek, A.; Korant, B.D. Inhibitory effect of carnosolic acid on HIV-1 protease in cell-free assays. J. Nat. Prod. 1993, 56, 1426–1430. [CrossRef] [PubMed]
259. Fu, M.; Ng, T.B.; Jiang, Y.; Pi, Z.F.; Liu, Z.K.; Li, L.; Liu, F. Compounds from rose (Rosa rugosa) flowers with human immunodeficiency virus type 1 reverse transcriptase inhibitory activity. J. Pharm. Pharmacol. 2006, 58, 1275–1280. [CrossRef] [PubMed]
260. Abd-Elazem, I.S.; Chen, H.S.; Bates, R.B.; Huang, R.C.C. Isolation of two highly potent and non-toxic inhibitors of human immunodeficiency virus type 1 (HIV-1) integrase from Salvia miltiorrhiza. Antivir. Res. 2002, 55, 91–106. [CrossRef]
261. Geuenich, S.; Goffinet, C.; Venzke, S.; Nolkemper, S.; Baumann, I.; Plinkert, P.; Reichling, J.; Keppler, O.T. Aqueous extracts from peppermint, sage and lemon balm leaves display potent anti-HIV-1 activity by increasing the virion density. Retrovirology 2008, 5, 27. [CrossRef] [PubMed]
262. Bailly, F.; Queffelec, C.; Mbemba, G.; Mouscadet, J.F.; Cotelle, P. Synthesis and HIV-1 integrase inhibitory activities of caffeic acid dimers derived from Salvia officinalis. Bioorgan. Med. Chem. Lett. 2005, 15, 5053–5056. [CrossRef] [PubMed]
263. Watanabe, M.; Kobayashi, Y.; Ogihara, J.; Kato, J.; Oishi, K. HIV-1 reverse transcriptase-inhibitory compound in Salvia officinalis. Food Sci. Technol. Res. 2000, 6, 216–220. [CrossRef]
264. Zhang, Z.F.; Peng, Z.G.; Gao, L.; Dong, B.; Li, J.R.; Li, Z.Y.; Chen, H.S. Three new derivatives of anti-HIV-1 polyphenols isolated from Salvia yunnanensis. J. Asian Nat. Prod. Res. 2008, 10, 391–396. [CrossRef] [PubMed]
265. Li, B.Q.; Fu, T.; Yan, Y.D.; Baylor, N.W.; Ruscetti, F.W.; Kung, H.F. Inhibition of HIV infection by baicalin-A flavonoid compound purified from Chinese herbal medicine. Cell. Mol. Biol. Res. 1993, 39, 119–124. [PubMed]
266. Wei, Y.; Ma, C.M.; Chen, D.Y.; Hattori, M. Anti-HIV-1 protease triterpenoids from Stauntonia obovatifoliola Hayata subsp. Intermedia. Phytochemistry 2008, 69, 1875–1879. [CrossRef] [PubMed]
267. Zhang, C.F.; Sun, Q.S.; Wáng, Z.T.; Masao, H.; Supinya, T. Inhibitory activities of tannins extracted from stem of Lindera aggregata against HIV-1 integrase. Chin. Pharm. J. 2003, 38, 911–914.
268. Zhang, C.F.; Nakamura, N.; Tewtrakul, S.; Hattori, M.; Sun, Q.S.; Wang, Z.T.; Fujiwara, T. Sesquiterpenes and alkaloids from Lindera chunii and their inhibitory activities against HIV-1 integrase. Chem. Pharm. Bull. 2002, 50, 1195–1200. [CrossRef] [PubMed]
269. Byung Sun, M.; Bae, K.; Young Ho, K.; Shimotohno, K.; Miyashiro, H.; Hattori, M. Inhibitory activities of Korean plants on HIV-1 protease. Nat. Prod. Sci. 1998, 4, 241–244.
270. Zhang, H.J.; Tan, G.T.; Hoang, V.D.; Hung, N.V.; Cuong, N.M.; Soejarto, D.D.; Pezzuto, J.M.; Fong, H.H.S. Natural anti-HIV agents. Part 2: Litseaverticillol a, a prototypic litseane sesquiterpene from Litsea verticillata. Tetrahedron Lett. 2001, 42, 8587–8591. [CrossRef]
271. He, J.; Chen, X.-Q.; Li, M.-M.; Zhao, Y.; Xu, G.; Cheng, X.; Peng, L.-Y.; Xie, M.-J.; Zheng, Y.-T.; Wang, Y.-P.; et al. Lycojapodine a, a novel alkaloid from Lycopodium japonicum. Organ. Lett. 2009, 11, 1397–1400. [CrossRef] [PubMed]
272. Sharma, A.; Rangari, V. HIV-1 reverse transcriptase and protease assay of methanolic extracts of Adansonia digitata L. Int. J. Pharm. Pharm. Sci. 2016, 8, 124–127. [CrossRef]
273. Subramanya, M.D.; Pai, S.R.; Upadhya, V.; Ankad, G.M.; Bhagwat, S.S.; Hegde, H.V. Total polyphenolic contents and in vitro antioxidant properties of eight Sida species from Western Ghats, India. J. Ayurveda Integr. Med. 2015, 6, 24–28. [PubMed]
274. Kainuma, M.; Baba, S.; Chan, H.T.; Inoue, T.; Tangah, J.; Chan, E.W.C. Medicinal plants of sandy shores: A short review on Calophyllum inophyllum and Thespesia populnea. Int. J. Pharmacogn. Phytochem. Res. 2016, 8, 2056–2062.
275. Puripattanavong, J.; Tungcharoen, P.; Chaniad, P.; Pianwanit, S.; Tewtrakul, S. Anti-HIV-1 integrase effect of compounds from Aglaia andamanica leaves and molecular docking study with acute toxicity test in mice. Pharm. Biol. 2016, 54, 654–659. [CrossRef] [PubMed]
276. Eid, A.M.M.; Elmarzugi, N.A.; El-Enshasy, H.A. A review on the phytopharmacological effect of Swietenia macrophylla. Int. J. Pharm. Pharm. Sci. 2013, 5, 47–53.
277. Matsuse, I.T.; Nakabayashi, T.; Lim, Y.A.; Hussein, G.M.E.; Miyashiro, H.; Kakiuchi, N.; Hattori, M.; Stardjo, S.; Shimotohno, K. A human immunodeficiency virus protease inhibitory substance from Swietenia mahagoni. Phytother. Res. 1997, 11, 433–436. [CrossRef]
278. Yan, M.H.; Cheng, P.; Jiang, Z.Y.; Ma, Y.B.; Zhang, X.M.; Zhang, F.X.; Yang, L.M.; Zheng, Y.T.; Chen, J.J. Periglaucines A-D, anti-HBV and -HIV-1 alkaloids from Pericampylus glaucus. J. Nat. Prod. 2008, 71, 760–763. [CrossRef] [PubMed]
279. Ma, C.M.; Nakamura, N.; Miyashiro, H.; Hattori, M.; Komatsu, K.; Kawahata, T.; Otake, T. Screening of Chinese and Mongolian herbal drugs for anti-human immunodeficiency virus type 1 (HIV-1) activity. Phytother. Res. 2002, 16, 186–189. [CrossRef] [PubMed]
280. Bunluepuech, K.; Tewtrakul, S. Anti-HIV-1 integrase activity of Thai medicinal plants. Songklanakarin J. Sci. Technol. 2009, 31, 289–292.
281. Bunluepuech, K.; Sudsai, T.; Wattanapiromsakul, C.; Tewtrakul, S. Inhibition on HIV-1 integrase activity and nitric oxide production of compounds from Ficus glomerata. Nat. Prod. Commun. 2011, 6, 1095–1098. [PubMed]
282. Groweiss, A.; Cardellina, J.H.; Boyd, M.R. HIV-Inhibitory Prenylated xanthones and flavones from Maclura tinctoria. J. Nat. Prod. 2000, 63, 1537–1539. [CrossRef] [PubMed]
283. Swanson, M.D.; Winter, H.C.; Goldstein, I.J.; Markovitz, D.M. A lectin isolated from bananas is a potent inhibitor of HIV replication. J. Biol. Chem. 2010, 285, 8646–8655. [CrossRef] [PubMed]
284. Kamng'Ona, A.; Moore, J.P.; Lindsey, G.; Brandt, W. Inhibition of HIV-1 and m-MLV reverse transcriptases by a major polyphenol (3,4,5 tri-O-galloylquinic acid) present in the leaves of the South African resurrection plant, Myrothamnus flabellifolia. J. Enzyme Inhib. Med. Chem. 2011, 26, 843–853. [CrossRef] [PubMed]
285. Bokesch, H.R.; Wamiru, A.; Le Grice, S.F.J.; Beutler, J.A.; McKee, T.C.; McMahon, J.B. HIV-1 ribonuclease H inhibitory phenolic glycosides from Eugenia hyemalis. J. Nat. Prod. 2008, 71, 1634–1636. [CrossRef] [PubMed]
286. Mao, Q.C.; Zhou, Y.C.; Li, R.M.; Hu, Y.P.; Liu, S.W.; Li, X.J. Inhibition of HIV-1 mediated cell-cell fusion by saponin fraction from Psidium guajava leaf. Zhong Yao Cai 2010, 33, 1751–1754. [PubMed]
287. Dai, J.P.; Zhao, X.F.; Zeng, J.; Wan, Q.Y.; Yang, J.C.; Li, W.Z.; Chen, X.X.; Wang, G.F.; Li, K.S. Drug screening for autophagy inhibitors based on the dissociation of beclin1-Bcl2 complex using BiFC technique and mechanism of eugenol on anti-influenza a virus activity. PLoS ONE 2013, 8, e61026. [CrossRef] [PubMed]
288. Goo, H.R.; Choi, J.S.; Na, D.H. Simultaneous determination of quercetin and its glycosides from the leaves of Nelumbo nucifera by reversed-phase high-performance liquid chromatography. Arch. Pharm. Res. 2009, 32, 201–206. [CrossRef] [PubMed]
289. Thomford, N.E.; Awortwe, C.; Dzobo, K.; Adu, F.; Chopera, D.; Wonkam, A.; Skelton, M.; Blackhurst, D.; Dandara, C. Inhibition of CYP2B6 by medicinal plant extracts: Implication for use of efavirenz and nevirapine based highly active anti-retroviral therapy (HAART) in resource-limited settings. Molecules 2016, 21, 211. [CrossRef] [PubMed]
290. Nugraha, A.S.; Hilou, A.; Vandegraaff, N.; Rhodes, D.I.; Haritakun, R.; Keller, P.A. Bioactive glycosides from the African medicinal plant Boerhavia erecta L. Nat. Prod. Res. 2015, 29, 1954–1958. [CrossRef] [PubMed]
291. Reutrakul, V.; Ningnuek, N.; Pohmakotr, M.; Yoosook, C.; Napaswad, C.; Kasisit, J.; Santisuk, T.; Tuchinda, P. Anti HIV-1 flavonoid glycosides from Ochna integerrima. Planta Med. 2007, 73, 683–688. [CrossRef] [PubMed]
292. Maroyi, A. Ximenia caffra Sond. (Ximeniaceae) in sub-Saharan Africa: A synthesis and review of its medicinal potential. J. Ethnopharmacol. 2016, 184, 81–100. [CrossRef] [PubMed]
293. Hatano, T.; Yasuhara, T.; Matsuda, M.; Yazaki, K.; Yoshida, T.; Okuda, T. Oenothein B, a dimeric hydrolyzable tannin of cyclic structure. Chem. Pharm. Bull. 1989, 37, 2269–2271. [CrossRef]
294. Hu, Q.F.; Zhou, B.; Huang, J.M.; Gao, X.M.; Shu, L.D.; Yang, G.Y.; Che, C.T. Antiviral phenolic compounds from Arundina gramnifolia. J. Nat. Prod. 2013, 76, 292–296. [CrossRef] [PubMed]
295. Bessong, P.O.; Rojas, L.B.; Obi, L.C.; Tshisikawe, P.M.; Igunbor, E.O. Further screening of venda medicinal plants for activity against HIV type 1 reverse transcriptase and integrase. Afr. J. Biotechnol. 2006, 5, 526–528.
296. Notka, F.; Meier, G.R.; Wagner, R. Inhibition of wild-type human immunodeficiency virus and reverse transcriptase inhibitor-resistant variants by Phyllanthus amarus. Antivir. Res. 2003, 58, 175–186. [CrossRef]
297. Ogata, T.; Higuchi, H.; Mochida, S.; Matsumoto, H.; Kato, A.; Endo, T.; Kaji, A.; Kaji, H. HIV-1 reverse transcriptase inhibitor from Phyllanthus niruri. AIDS Res. Hum. Retrovir. 1992, 8, 1937–1944. [CrossRef] [PubMed]
298. Eberhardt, T.L.; Young, R.A. Assessment of the anti-HIV activity of a pine cone isolate. Planta Med. 1996, 62, 63–65. [CrossRef] [PubMed]
299. Lai, P.K.; Donovan, J.; Takayama, H.; Sakagami, H.; Tanaka, A.; Konno, K.; Nonoyama, M. Modification of human immunodeficiency viral replication by pine cone extracts. AIDS Res. Hum. Retrovir. 1990, 6, 205–217. [CrossRef] [PubMed]
300. Porika, M.; Aileni, M.; Kokkirala, V.R.; Gadidasu, K.; Umate, P.; Rao, A.V.; Devarakonda, R.K.; Abbagani, S. In vitro HIV type-1 reverse transcriptase inhibitory activity from leaf extracts of Scoparia dulcis L. J. Herbs Spices Med. Plants 2009, 15, 241–247. [CrossRef]
301. Esposito, F.; Carli, I.; Del Vecchio, C.; Xu, L.; Corona, A.; Grandi, N.; Piano, D.; Maccioni, E.; Distinto, S.; Parolin, C.; et al. Sennoside a, derived from the traditional Chinese medicine plant Rheum L., is a new dual HIV-1 inhibitor effective on HIV-1 replication. Phytomedicine 2016, 23, 1383–1391. [CrossRef] [PubMed]
302. Zhao, X.H.; Han, F.; Li, Y.L.; Yue, H.L. Preparative isolation and purification of three stilbene glycosides from the Tibetan medicinal plant Rheum tanguticum Maxim. Ex Balf. By high-speed counter-current chromatography. Phytochem. Anal. 2013, 24, 171–175. [CrossRef] [PubMed]
303. Piacente, S.; Pizza, C.; De Tommasi, N.; Mahmood, N. Constituents of Ardisia japonica and their in vitro anti-HIV activity. J. Nat. Prod. 1996, 59, 565–569. [CrossRef] [PubMed]
304. Dai, J.-R.; Decosterd, L.A.; Gustafson, K.R.; Cardellina, J.H.; Gray, G.N.; Boyd, M.R. Novel naphthoquinones from Conospermum incurvum. J. Nat. Prod. 1994, 57, 1511–1516. [CrossRef] [PubMed]
305. Min, B.S.; Jung, H.J.; Lee, J.S.; Kim, Y.H.; Bok, S.H.; Ma, C.M.; Nakamura, N.; Hattori, M.; Bae, K. Inhibitory effect of triterpenes from Crataegus pinatifida on HIV-I protease. Planta Med. 1999, 65, 374–375. [CrossRef] [PubMed]
306. Mahmood, N.; Piacente, S.; Pizza, C.; Burke, A.; Khan, A.I.; Hayt, A.J. The anti-HIV activity and mechanisms of action of pure compounds isolated from Rosa damascena. Biochem. Biophys. Res. Commun. 1996, 229, 73–79. [CrossRef] [PubMed]
307. Jong Cheol, P.; Suk Nam, K.; Kwang Jin, C.; Jong Won, C. Anti-HIV-1 protease activity and in vivo anti-lipid peroxidative effect on Rosa davurica. Korean J. Pharmacogn. 2000, 31, 264–267.
308. Liang, J.; Chen, J.; Tan, Z.; Peng, J.; Zheng, X.; Nishiura, K.; Ng, J.; Wang, Z.; Wang, D.; Chen, Z.; et al. Extracts of the medicinal herb Sanguisorba officinalis inhibit the entry of human immunodeficiency virus-1. J. Food Drug Anal. 2013, 21, S52–S58. [CrossRef] [PubMed]
309. Chinnaiyan, S.K.; Subramanian, M.R.; Vinoth Kumar, S.; Chandu, A.N.; Deivasigamani, K. Antimicrobial and anti-HIV activity of extracts of Canthium coromandelicum (Burm.F.) Alston leaves. J. Pharm. Res. 2013, 7, 588–594. [CrossRef]
310. Reutrakul, V.; Krachangchaeng, C.; Tuchinda, P.; Pohmakotr, M.; Jaipetch, T.; Yoosook, C.; Kasisit, J.; Sophasan, S.; Sujarit, K.; Santisuk, T. Cytotoxic and anti-HIV-1 constituents from leaves and twigs of Gardenia tubifera. Tetrahedron 2004, 60, 1517–1523. [CrossRef]
311. Lamorde, M.; Tabuti, J.R.S.; Obua, C.; Kukunda-Byobona, C.; Lanyero, H.; Byakika-Kibwika, P.; Bbosa, G.S.; Lubega, A.; Ogwal-Okeng, J.; Ryan, M.; et al. Medicinal plants used by traditional medicine practitioners for the treatment of HIV/AIDS and related conditions in Uganda. J. Ethnopharmacol. 2010, 130, 43–53. [CrossRef] [PubMed]
312. Ayisi, N.K.; Nyadedzor, C. Comparative in vitro effects of azt and extracts of Ocimum gratissimum, Ficus polita, Clausena anisata, Alchornea cordifolia, and Elaeophorbia drupifera against HIV-1 and HIV-2 infections. Antivir. Res. 2003, 58, 25–33. [CrossRef]
313. Sunthitikawinsakul, A.; Kongkathip, N.; Kongkathip, B.; Phonnakhu, S.; Daly, J.W.; Spande, T.F.; Nimit, Y.; Napaswat, C.; Kasisit, J.; Yoosook, C. Anti-HIV-1 limonoid: First isolation from Clausena excavata. Phytother. Res. 2003, 17, 1101–1103. [CrossRef] [PubMed]
314. Rashid, M.; Gustafson, K.; Kashmani, Y.; Cardellina, J., III; McMahon, J.; Boyd, M. Anti-HIV alkaloids from Toddalia asiatica. Nat. Prod. Lett. 1995, 6, 153–156. [CrossRef]
315. Kim, H.J.; Woo, E.-R.; Shin, C.-G.; Park, H. A new flavonol glycoside gallate ester from Acer okamotoanum and its inhibitory activity against human immunodeficiency virus-1 (HIV-1) integrase. J. Nat. Prod. 1998, 61, 145–148. [CrossRef] [PubMed]
316. Yang, X.W.; Zhao, J.; Cui, Y.X.; Liu, X.H.; Ma, C.M.; Hattori, M.; Zhang, L.H. Anti-HIV-1 protease triterpenoid saponins from the seeds of Aesculus chinensis. J. Nat. Prod. 1999, 62, 1510–1513. [CrossRef] [PubMed]
317. Suedee, A.; Tewtrakul, S.; Panichayupakaranant, P. Anti-HIV-1 integrase compound from Pometia pinnata leaves. Pharm. Biol. 2013, 51, 1256–1261. [CrossRef] [PubMed]
318. Fang, E.F.; Ng, T.B. A trypsin inhibitor from rambutan seeds with antitumor, anti-HIV-1 reverse transcriptase, and nitric oxide-inducing properties. Appl. Biochem. Biotechnol. 2015, 175, 3828–3839. [CrossRef] [PubMed]
319. Sahu, N.P.; Mandal, N.B.; Banerjee, S.; Siddiqui, K.A.I. Chemistry and biology of the triterpenes and saponins from seeds of Mimusops elengi. J. Herbs Spices Med. Plants 2001, 8, 29–37. [CrossRef]
320. Gosse, B.; Gnabre, J.; Bates, R.B.; Dicus, C.W.; Nakkiew, P.; Huang, R.C.C. Antiviral saponins from Tieghemella heckelii. J. Nat. Prod. 2002, 65, 1942–1944. [CrossRef] [PubMed]
321. Hayashi, K.; Kamiya, M.; Hayashi, T. Virucidal effects of the steam distillate from Houttuynia cordata and its components on HSV-1, influenza virus, and HIV. Planta Med. 1995, 61, 237–241. [CrossRef] [PubMed]
322. Lee, J.; Huh, M.S.; Kim, Y.C.; Hattori, M.; Otake, T. Lignan, sesquilignans and dilignans, novel HIV-1 protease and cytopathic effect inhibitors purified from the rhizomes of Saururus chinensis. Antivir. Res. 2010, 85, 425–428. [CrossRef] [PubMed]
323. Song, W.Y.; Ma, Y.B.; Bai, X.; Zhang, X.M.; Gu, Q.; Zheng, Y.T.; Zhou, J.; Chen, J.J. Two new compounds and anti-HIV active constituents from Illicium verum. Planta Med. 2007, 73, 372–375. [CrossRef] [PubMed]
324. Gao, X.-M.; Pu, J.-X.; Huang, S.-X.; Yang, L.-M.; Huang, H.; Xiao, W.-L.; Zheng, Y.-T.; Sun, H.-D. Lignans from Kadsura angustifolia. J. Nat. Prod. 2008, 71, 558–563. [CrossRef] [PubMed]
325. Xu, L.J.; Peng, Z.G.; Chen, H.S.; Wang, J.; Xiao, P.G. Bioactive triterpenoids from Kadsura heteroclita. Chem. Biodivers. 2010, 7, 2289–2295. [CrossRef] [PubMed]
326. Pu, J.X.; Yang, L.M.; Xiao, W.L.; Li, R.T.; Lei, C.; Gao, X.M.; Huang, S.X.; Li, S.H.; Zheng, Y.T.; Huang, H.; et al. Compounds from Kadsura heteroclita and related anti-HIV activity. Phytochemistry 2008, 69, 1266–1272. [CrossRef] [PubMed]
327. Sun, Q.Z.; Chen, D.F.; Ding, P.L.; Ma, C.M.; Kakuda, H.; Nakamura, N.; Hattori, M. Three new lignans, longipedunins A-C, from Kadsura longipedunculata and their inhibitory activity against HIV-1 protease. Chem. Pharm. Bull. 2006, 54, 129–132. [CrossRef] [PubMed]
328. Xiao, W.-L.; Tian, R.-R.; Pu, J.-X.; Li, X.; Wu, L.; Lu, Y.; Li, S.-H.; Li, R.-T.; Zheng, Y.-T.; Zheng, Q.-T.; et al. Triterpenoids from Schisandra lancifolia with anti-HIV-1 activity. J. Nat. Prod. 2006, 69, 277–279. [CrossRef] [PubMed]
329. Xiao, W.L.; Huang, S.X.; Zhang, L.; Tian, R.R.; Wu, L.; Li, X.L.; Pu, J.X.; Zheng, Y.T.; Lu, Y.; Li, R.T.; et al. Nortriterpenoids from Schisandra lancifolia. J. Nat. Prod. 2006, 69, 650–653. [CrossRef] [PubMed]
330. Li, X.-N.; Pu, J.-X.; Du, X.; Yang, L.-M.; An, H.-M.; Lei, C.; He, F.; Luo, X.; Zheng, Y.-T.; Lu, Y.; et al. Lignans with anti-HIV activity from Schisandra propinqua var. sinensis. J. Nat. Prod. 2009, 72, 1133–1141. [CrossRef] [PubMed]
331. Xiao, W.-L.; Li, X.L.; Wang, R.-R.; Yang, L.-M.; Li, L.M.; Huang, S.-X.; Pu, J.-X.; Zheng, Y.-T.; Li, R.-T.; Sun, H.-D. Triterpenoids from Schisandra rubriflora. J. Nat. Prod. 2007, 70, 1056–1059. [CrossRef] [PubMed]
332. Sun, H.; Qiu, S.; Lin, L.; Wang, Z.; Lin, Z.; Pengsuparp, T.; Pezzuto, J.M.; Fong, H.H.S.; Cordell, G.A.; Farnsworth, N.R. Nigranoic acid, a triterpenoid from Schisandra sphaerandra that inhibits HIV-1 reverse transcriptase. J. Nat. Prod. 1996, 59, 525–527. [CrossRef] [PubMed]
333. Xiao, W.L.; Pu, J.X.; Chang, Y.; Li, X.L.; Huang, S.X.; Yang, L.M.; Li, L.M.; Lu, Y.; Zheng, Y.T.; Li, R.T.; et al. Sphenadilactones A and B, two novel nortriterpenoids from Schisandra sphenanthera. Organ. Lett. 2006, 8, 1475–1478. [CrossRef] [PubMed]
334. Liang, C.Q.; Luo, R.H.; Yan, J.M.; Li, Y.; Li, X.N.; Shi, Y.M.; Shang, S.Z.; Gao, Z.H.; Yang, L.M.; Zheng, Y.T.; et al. Structure and bioactivity of triterpenoids from the stems of Schisandra sphenanthera. Arch. Pharm. Res. 2014, 37, 168–174. [CrossRef] [PubMed]
335. Yang, G.Y.; Li, Y.K.; Wang, R.R.; Xiao, W.L.; Yang, L.M.; Pu, J.X.; Zheng, Y.T.; Sun, H.D. Dibenzocyclooctadiene lignans from the fruits of Schisandra wilsoniana and their anti-HIV-1 activities. J. Asian Nat. Prod. Res. 2010, 12, 470–476. [CrossRef] [PubMed]
336. Xu, Z.; Chang, F.-R.; Wang, H.-K.; Kashiwada, Y.; McPhail, A.T.; Bastow, K.F.; Tachibana, Y.; Cosentino, M.; Lee, K.-H. Anti-HIV agents 45 and antitumor agents 205. Two new sesquiterpenes, leitneridanins A and B, and the cytotoxic and anti-HIV principles from Leitneria floridana. J. Nat. Prod. 2000, 63, 1712–1715. [CrossRef] [PubMed]
337. Wang, W.X.; Qian, J.Y.; Wang, X.J.; Jiang, A.P.; Jia, A.Q. Anti-HIV-1 activities of extracts and phenolics from Smilax china L. Pakistan J. Pharm. Sci. 2014, 27, 147–151.
338. Shy, S.N.; Chang, W.T.; Lee, S.S.; Chen Liu, K.C.S. Production of triterpenes from cell suspension cultures of Solanum incanum L. Chin. Pharm. J. 2000, 52, 35–42.
339. Mamba, P.; Adebayo, S.A.; Tshikalange, T.E. Anti-microbial, anti-inflammatory and HIV-1 reverse transcriptase activity of selected South African plants used to treat sexually transmitted diseases. Int. J. Pharmacogn. Phytochem. Res. 2016, 8, 1870–1876.
340. Kumar, S.; Pandey, A.K. Medicinal attributes of Solanum xanthocarpum fruit consumed by several tribal communities as food: An in vitro antioxidant, anticancer and anti HIV perspective. BMC Complement. Altern. Med. 2014, 14, 112. [CrossRef] [PubMed]
341. Rege, A.A.; Chowdhary, A.S. Evaluation of some medicinal plants as putative HIV-protease inhibitors. Indian Drugs 2013, 50, 24–28.
342. Wu, N.; Wang, L.; Chzn, Y.K.; Liao, Z.; Yang, G.Y.; Hu, Q.F. Lignans from the stem of Styrax japonica. Asian J. Chem. 2011, 23, 931–932.
343. Park, J.C.; Hur, J.M.; Park, J.G.; Hatano, T.; Yoshida, T.; Miyashiro, H.; Min, B.S.; Hattori, M. Inhibitory effects of Korean medicinal plants and camelliatannin H from Camellia japonica on human immunodeficiency virus type 1 protease. Phytother. Res. 2002, 16, 422–426. [CrossRef] [PubMed]
344. Zhang, X.; Huang, S.Z.; Gu, W.G.; Yang, L.M.; Chen, H.; Zheng, C.B.; Zhao, Y.X.; Wan, D.C.C.; Zheng, Y.T. Wikstroelide M potently inhibits HIV replication by targeting reverse transcriptase and integrase nuclear translocation. Chin. J. Nat. Med. 2014, 12, 186–193. [CrossRef]
345. Hu, Q.F.; Mu, H.X.; Huang, H.T.; Lv, H.Y.; Li, S.L.; Tu, P.F.; Li, G.P. Secolignans, neolignans and phenylpropanoids from Daphne feddei and their biological activities. Chem. Pharm. Bull. 2011, 59, 1421–1424. [CrossRef] [PubMed]
346. Rahman, M.K.; Chowdhury, M.A.; Islam, M.F.; Barua, S.; Rahman, M.A. Antidiarrheal and thrombolytic effects of methanol extract of Wikstroemia indica (L.) C. A. Mey leaves. Int. J. Green Pharm. 2015, 9, 8–13. [CrossRef]
347. Charan, R.D.; Munro, M.H.G.; O’Keefe, B.R.; Sowder Ii, R.C.; McKee, T.C.; Currens, M.J.; Pannell, L.K.; Boyd, M.R. Isolation and characterization of Myrianthus holstii lectin, a potent HIV-1 inhibitory protein from the plant Myrianthus holstii. J. Nat. Prod. 2000, 63, 1170–1174. [CrossRef] [PubMed]
348. Piccinelli, A.L.; Mahmood, N.; Mora, G.; Poveda, L.; De Simone, F.; Rastrelli, L. Anti-HIV activity of dibenzylbutyrolactone-type lignans from Phenax species endemic in Costa Rica. J. Pharm. Pharmacol. 2005, 57, 1109–1115. [CrossRef] [PubMed]
349. Turville, S.G.; Vermeire, K.; Balzarini, J.; Schols, D. Sugar-binding proteins potently inhibit dendritic cell human immunodeficiency virus type 1 (HIV-1) infection and dendritic-cell-directed HIV-1 transfer. J. Virol. 2005, 79, 13519–13527. [CrossRef] [PubMed]
350. Mujovo, S.; Hussein, A.; Meyer, J.J.M.; Fourie, B.; MutHIVhi, T.; Lall, N. Bioactive compounds from Lippia javanica and Hoslundia opposita. Nat. Prod. Res. 2008, 22, 1047–1054. [CrossRef] [PubMed]
351. Pflieger, A.; Teguo, P.W.; Papastamoulis, Y.; Chaignepain, S.; Subra, F.; Munir, S.; Delelis, O.; Lesbats, P.; Calmels, C.; Andreola, M.L.; et al. Natural stilbenoids isolated from grapevine exhibiting inhibitory effects against HIV-1 integrase and eukaryote MOS1 transposase in vitro activities. PLoS ONE 2013, 8, e81184. [CrossRef] [PubMed]
352. Afolayan, A.J.; Grierson, D.S.; Mbeng, W.O. Ethnobotanical survey of medicinal plants used in the management of skin disorders among the Xhosa communities of the Amathole district, Eastern Cape, South Africa. J. Ethnopharmacol. 2014, 153, 220–232. [CrossRef] [PubMed]
353. Olatunya, O.S.; Olatunya, A.M.; Anyabolu, H.C.; Adejuyigbe, E.A.; Oyelami, O.A. Preliminary trial of Aloe vera gruel on HIV infection. J. Altern. Complement. Med. 2012, 18, 850–853. [CrossRef] [PubMed]
354. Sookkongwaree, K.; Geitmann, M.; Roengsumran, S.; Petsom, A.; Danielson, U.H. Inhibition of viral proteases by Zingiberaceae extracts and flavones isolated from Kaempferia parviflora. Pharmazie 2006, 61, 717–721. [PubMed]
355. Voravuthikunchai, S.P.; Phongpaichit, S.; Subhadhirasakul, S. Evaluation of antibacterial activities of medicinal plants widely used among AIDS patients in Thailand. Pharm. Biol. 2005, 43, 701–706. [CrossRef]
356. Tan, E.C.; Karsani, S.A.; Foo, G.T.; Wong, S.M.; Abdul Rahman, N.; Khalid, N.; Othman, S.; Yusof, R. Proteomic analysis of cell suspension cultures of Boesenbergia rotunda induced by phenylalanine: Identification of proteins involved in flavonoid and phenylpropanoid biosynthesis pathways. Plant Cell Tissue Organ Cult. 2012, 111, 219–229. [CrossRef]
357. Md-Mustafa, N.D.; Khalid, N.; Gao, H.; Peng, Z.; Alimin, M.F.; Bujang, N.; Ming, W.S.; Mohd-Yusuf, Y.; Harikrishna, J.A.; Othman, R.Y. Transcriptome profiling shows gene regulation patterns in a flavonoid pathway in response to exogenous phenylalanine in Boesenbergia rotunda cell culture. BMC Genom. 2014, 15. [CrossRef] [PubMed]
358. Mesa, M.D. Pharmacological and nutritional effects of Curcuma longa L. extracts and curcuminoids. Ars Pharm. 2000, 41, 307–321.
359. Gnabre, J.N.; Brady, J.N.; Clanton, D.J.; Ito, Y.; Dittmer, J.; Bates, R.B.; Huang, R.C.C. Inhibition of human immunodeficiency virus type 1 transcription and replication by DNA sequence-selective plant lignans. Proc. Natl. Acad. Sci. USA 1995, 92, 11239–11243. [CrossRef] [PubMed]
360. Borris, R.P. Natural products research: Perspectives from a major pharmaceutical company. J. Ethnopharmacol. 1996, 51, 29–38. [CrossRef]
361. Yang, S.S.; Cragg, G.M.; Newman, D.J.; Bader, J.P. Natural product-based anti-HIV drug discovery and development facilitated by the NCI developmental therapeutics program. J. Nat. Prod. 2001, 64, 265–277. [CrossRef] [PubMed]
362. Sarin, P.S. Molecular pharmacologic approaches to the treatment of AIDS. Annu. Rev. Pharmacol. Toxicol. 1988, 28, 411–428. [CrossRef] [PubMed]
363. Vlietinck, A.J.; Berghe, D.A.V. Can ethnopharmacology contribute to the development of antiviral drgs? J. Ethnopharmacol. 1991, 32, 141–153. [CrossRef]
364. Harvey, A. Strategies for discovering drugs from previously unexplored natural products. Drug Discov. Today 2000, 5, 294–300. [CrossRef]
365. Beutler, J.A. Natural products as a foundation for drug discovery. Curr. Protoc. Pharmacol. 2009, 46, 9–11. [CrossRef] [PubMed]
366. Vlietinck, A.; De Bruyne, T.; Apers, S.; Pieters, L. Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection. Planta Med. 1998, 64, 97–109. [CrossRef] [PubMed]
367. De Clercq, E. Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection. Med. Res. Rev. 2000, 20, 323–349. [CrossRef]
368. Jadaun, P.; Khopkar, P.; Kulkarni, S. Repurposing Phytochemicals as Anti-HIV Agents. J. Antivir. Antiretrovir. 2016, 8, 139–141. [CrossRef]
369. Lubbe, A.; Seibert, I.; Klimkait, T.; Van der Kooy, F. Ethnopharmacology in overdrive: The remarkable anti-HIV activity of Artemisia annua. J. Ethnopharmacol. 2012, 141, 854–859. [CrossRef] [PubMed]
370. Burack, J.H.; Cohen, M.R.; Hahn, J.A.; Abrams, D.I. Pilot randomized controlled trial of Chinese herbal treatment for HIV-associated symptoms. J. Acquir. Immune Defic. Syndr. 1996, 12, 386–393. [CrossRef]
371. Kalvatchev, Z.; Walder, R.; Garzaro, D. Anti-HIV activity of extracts from Calendula officinalis flowers. Biomed. Pharmacother. 1997, 51, 176–180. [CrossRef]
372. Pengsuparp, T.; Serit, M.; Hughes, S.H.; Soejarto, D.D.; Pezzuto, J.M. Specific inhibition of human immunodeficiency virus type 1 reverse transcriptase mediated by soulattrolide, a coumarin isolated from the latex of Calophyllum teysmannii. J. Nat. Prod. 1996, 59, 839–842. [CrossRef] [PubMed]
373. Leteane, M.M.; Ngwenya, B.N.; Muzila, M.; Namushe, A.; Mwinga, J.; Musonda, R.; Moyo, S.; Mengestu, Y.B.; Abegaz, B.M.; Andrae-Marobela, K. Old plants newly discovered: Cassia sieberiana DC and Cassia abbreviata Oliv. Oliv. root extracts inhibit in vitro HIV-1C replication in peripheral blood mononuclear cells (pbmcs) by different modes of action. J. Ethnopharmacol. 2012, 141, 48–56. [CrossRef] [PubMed]
374. Gerenčer, M.; Turecek, P.L.; Kistner, O.; Mitterer, A.; Savidis-Dacho, H.; Barrett, N.P. In vitro and in vivo anti-retroviral activity of the substance purified from the aqueous extract of Chelidonium majus L. Antivir. Res. 2006, 72, 153–156. [CrossRef] [PubMed]
375. Rashed, K.; Zhang, X.-J.; Luo, M.-T.; Zheng, Y.-T. Anti-HIV-1 activity of phenolic compounds isolated from Diospyros lotus fruits. Phytopharmacology 2012, 3, 199–207.
376. Bedoya, L.; Palomino, S.S.; Abad, M.; Bermejo, P.; Alcami, J. Screening of selected plant extracts for in vitro inhibitory activity on human immunodeficiency virus. Phytother. Res. 2002, 16, 550–554. [CrossRef] [PubMed]
377. Wu, L.; Bao, J.-k. Anti-tumor and anti-viral activities of Galanthus nivalis agglutinin (Gna)-related lectins. Glycoconj. J. 2013, 30, 269–279. [CrossRef] [PubMed]
378. Magadula, J.J. A bioactive isoprenylated xanthone and other constituents of Garcinia edulis. Fitoterapia 2010, 81, 420–423. [CrossRef] [PubMed]
379. Hudson, J.; Harris, L.; Towers, G. The importance of light in the anti-HIV effect of hypericin. Antivir. Res. 1993, 20, 173–178. [CrossRef]
380. Gulick, R.M.; McAuliffe, V.; Holden-Wiltse, J.; Crumpacker, C.; Liebes, L.; Stein, D.S.; Meehan, P.; Hussey, S.; Forcht, J.; Valentine, F.T. Phase I studies of hypericin, the active compound in St. John’s wort, as an antiretroviral agent in HIV-infected adults: AIDS clinical trials group protocols 150 and 258. Ann. Intern. Med. 1999, 130, 510–514. [CrossRef] [PubMed]
381. Zhang, H.-J.; Rumschlag-Booms, E.; Guan, Y.-F.; Wang, D.-Y.; Liu, K.-L.; Li, W.-F.; Nguyen, V.H.; Cuong, N.M.; Soejarto, D.D.; Fong, H.H. Potent inhibitor of drug-resistant HIV-1 strains identified from the medicinal plant Justicia gendarussa. J. Nat. Prod. 2017, 80, 1798–1807. [CrossRef] [PubMed]
382. Jiratchariyakul, W.; Wiwat, C.; Vongsakul, M.; Somanabandhu, A.; Leelamanit, W.; Fujii, I.; Suwannaroj, N.; Ebizuka, Y. HIV inhibitor from Thai bitter gourd. Planta Med. 2001, 67, 350–353. [CrossRef] [PubMed]
383. Bot, Y.; Mgbojikwe, L.; Nwosu, C.; Abimiku, A.; Dadik, J.; Damshak, D. Screening of the fruit pulp extract of Momordica balsamina for anti HIV property. Afr. J. Biotechnol. 2007, 6, 47–52.
384. Eldeen, I.; Seow, E.; Abdullah, R.; Sulaiman, S. In vitro antibacterial, antioxidant, total phenolic contents and anti-HIV-1 reverse transcriptase activities of extracts of seven Phyllanthus sp. S. Afr. J. Bot. 2011, 77, 75–79. [CrossRef]
385. Wang, R.-R.; Gu, Q.; Yang, L.-M.; Chen, J.-J.; Li, S.-Y.; Zheng, Y.-T. Anti-HIV-1 activities of extracts from the medicinal plant Rhus chinensis. J. Ethnopharmacol. 2006, 105, 269–273. [CrossRef] [PubMed]
386. Durge, A.; Jadaun, P.; Wadhwani, A.; Chinchansure, A.A.; Said, M.; Thulasiram, H.; Joshi, S.P.; Kulkarni, S.S. Acetone and methanol fruit extracts of Terminalia paniculata inhibit HIV-1 infection in vitro. Nat. Prod. Res. 2017, 31, 1468–1471. [CrossRef] [PubMed]
387. Jian, W.; Feng-Zhen, Y.; Min, Z.; Yun-Hui, Z.; Yong-Xiang, Z.; Ying, L.; Wei-Min, L.; Fu-Sheng, W.; Shu-Ling, X.; Zhi-Min, Y. Randomized double-blinded and controlled clinical trial on treatment of HIV/AIDS by zhongyan-4. Chin. J. Integr. Med. 2006, 12, 6–11. [CrossRef]
388. Zhang, L.; Yue, S.-T.; Xue, Y.-X.; Attele, A.S.; Yuan, C.-S. Effects of Qian-Kun-Nin, a Chinese herbal medicine formulation, on HIV positive subjects: A pilot study. Am. J. Chin. Med. 2000, 28, 305–312. [CrossRef] [PubMed]
389. Colebunders, R.; Dreezen, C.; Florence, E.; Pelgrom, Y.; Schrooten, W. The use of complementary and alternative medicine by persons with HIV infection in Europe. Int. J. STD AIDS 2003, 14, 672–674. [CrossRef] [PubMed]
390. Owen-Smith, A.; Diclemente, R.; Wingood, G. Complementary and alternative medicine use decreases adherence to HAART in HIV-positive women. AIDS Care 2007, 19, 589–593. [CrossRef] [PubMed]
391. Tshibangu, K.; Worku, Z.; De Jongh, M.; Van Wyk, A.; Mokwena, S.; Peranovic, V. Assessment of effectiveness of traditional herbal medicine in managing HIV/AIDS patients in south Africa. East Afr. Med. J. 2004, 81, 499–504. [CrossRef] [PubMed]
392. Mills, E.; Cooper, C.; Seely, D.; Kanfer, I. African herbal medicines in the treatment of HIV: Hypoxis and Sutherlandia. An overview of evidence and pharmacology. Nutr. J. 2005, 4, 19. [CrossRef] [PubMed]
393. Tani, M.; Nagase, M.; Nishiyama, T.; Yamamoto, T.; Matusa, R. The effects of long-term herbal treatment for pediatric AIDS. Am. J. Chin. Med. 2002, 30, 51–64. [CrossRef] [PubMed]
394. Djohan, Y.; Camara, C.; Monde, A.; Koffi, G.; Niamké, G.; Déré, L.; Tiahou, G.; Djessou, P.; Sess, D. Interest of antioxidants in the care of the patients infected by the HIV: The experience of long term administration of alternanthera pungens herb tea. Ann. Biol. Clin. 2009, 67, 563–568.